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Aim: DNA methylation programs gene expression and is involved in numerous 27 
biological processes. Accumulating evidence supports transgenerational inheritance 28 
of DNA methylation changes in mammals via germ cells. Our aim was to determine 29 
the effect of exercise on sperm DNA methylation. 30 
Materials and Methods: Twenty-four men were recruited and assigned to an 31 
exercise intervention or control group. Clinical parameters were measured and 32 
sperm samples were donated by subjects before and after the three month time-33 
period. Mature sperm global and genome-wide DNA methylation was assessed 34 
using an ELISA assay and the 450K BeadChip (Illumina). 35 
Results: Global and genome-wide sperm DNA methylation was altered after three 36 
months of exercise training. DNA methylation changes occurred in genes related to 37 
numerous diseases such as Schizophrenia and Parkinson’s disease.  38 
Conclusions: Our study provides the first evidence showing exercise training 39 
reprograms the sperm methylome. Whether these DNA methylation changes are 40 











Executive summary 51 
Aim 52 
• To determine the impact of exercise training on human sperm DNA 53 
methylation. 54 
Materials and Methods 55 
• Twenty-four healthy young men were recruited and allocated to an exercise 56 
training or control group. 57 
• Health and fitness parameters were measured and sperm samples were 58 
collected before and after three months. 59 
• Global and genome-wide DNA methylation was quantified using an ELISA 60 
assay and the Infinium HumanMethylation450 BeadChip (Illumina), 61 
respectively.  62 
• Significant alterations in CpG methylation and corresponding gene pathways 63 
modulated by exercise training were analysed using Partek (Genomic Suite). 64 
The disease association was performed using the Database for Annotation, 65 
Visualization and Integrated Discovery (DAVID). 66 
Discussion 67 
• Exercise training was associated with global demethylation of human sperm. 68 
•  DNA methylation changes occurred across the genome after exercise 69 
training in genes enriched for numerous developmental processes and 70 
pathways associated with the adaptation to exercise training.  71 
• Genes related to disease were methylated after exercise, indicating 72 





• We provide the first evidence demonstrating exercise training regulates the 77 
human sperm methylome at CpG sites in genes associated with disease. 78 
 79 
Introduction 80 
DNA methylation is crucial for long-term gene expression regulation [1, 2]. DNA 81 
methylation is, however, reprogrammable through environmental conditions [3, 4]. 82 
Aberrant DNA methylation signatures are associated with age-related diseases such 83 
as cancer [5-7], atherosclerosis [8, 9], type 2 diabetes mellitus [10, 11], Alzheimer’s 84 
disease [12] and major psychosis disorders [13, 14].  85 
Mounting evidence indicates that environmentally induced DNA methylation changes 86 
are inherited by subsequent generations and affects their phenotypes [15-22]. A 87 
likely mechanism for inheritance of DNA methylation profile is via the germ cells. 88 
Interestingly, aging is associated with sperm DNA methylation changes and may 89 
influence disease risk of future generations [23, 24]. The differentially methylated 90 
regions in sperm obtained from old (12–14 month-old) versus young (3-month-old) 91 
mice were observed in the brain of the subsequent offspring, causing altered gene 92 
expression and increased behaviors associated with psychiatric disorders 93 
(schizophrenia and autism spectrum disorder) [24]. Although aging has been 94 
investigated in context with sperm DNA methylation, the influence of other favorable 95 
environmental stimuli are yet to be determined.  96 
We recently found that exercise training significantly improves cardiorespiratory 97 
fitness and lipid profile in conjunction with genome-wide leukocyte methylation 98 
changes in young men [25]. Others have shown that exercise training modulates 99 
skeletal myocyte [26-28] and adipocyte [29] DNA methylation as well as improving 100 
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health and fitness phenotypes. Thus, somatic cells are vulnerable to epigenetic 101 
changes caused by exercise training, but whether exercise training regulates DNA 102 
methylation is germ cells (oocyte or sperm) is currently unknown. 103 
The aim of this study was to determine the impact of exercise training on human 104 
sperm DNA methylation. Considering the mounting evidence supporting exercise 105 
training as an environmental modulator of somatic cell DNA methylation [25-29], we 106 
hypothesized that exercise training would significantly modify sperm DNA 107 
methylation in genes related to human diseases. 108 
 109 
Materials and methods 110 
Subjects 111 
Twenty-four healthy young men were recruited for this study. Subjects were non-112 
smoking, not taking any medications and free from any age-related chronic diseases, 113 
according to self-administered health questionnaires. Subjects were eligible if they 114 
had not engaged in any structured high-intensity aerobic exercise training during the 115 
past six months and were recruited predominantly from the University by flyers and 116 
by word-of-mouth.  117 
The subjects’ characteristics are outlined in Table 1. All subjects gave written 118 
informed consent to participate and this study was approved by the Federation 119 
University Australia Human Research Ethics Committee. 120 
Procedures 121 
On the initial day of testing, subjects were asked to complete health and physical 122 
activity questionnaires in order to establish their eligibility to participate in the study. 123 
Subjects were also familiarized with the testing procedures to follow and were given 124 
a collection tube for their sperm donation.  125 
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The second testing session involved a sperm donation, blood donation, physical 126 
measures and a test of maximal oxygen uptake (V̇O2max) on a treadmill. All testing 127 
sessions were performed in the morning (7–10 AM). Height, weight and body mass 128 
index were recorded using scales and a stadiometer. Blood pressure was measured 129 
and augmentation index was assessed by non-invasive applanation tonometry using 130 
the SphygmoCor instrument (AtCor, Australia). Subjects completed a maximal 131 
treadmill exercise test to assess V̇O2max. After a three minute warm-up, subjects 132 
began running at 10 km.h-1 and the treadmill speed was progressively increased by 1 133 
km.h-1 every second minute until the volitional exhaustion or the supervising Exercise 134 
Physiologist deemed it appropriate to stop the test. Participants were fitted with a 135 
two-way breathing valve (Hans Rudolph) and breath-by-breath analysis was 136 
performed by the online metabolic system (Moxus, Modular, USA). V̇O2max was 137 
determined as the highest O2 value averaged over 60 s. Maximal treadmill speed 138 
was deemed the highest speed successfully completed and was adjusted for time so 139 
that participants were encouraged to exercise to their limit. The same testing 140 
procedures were completed 3–5 days after the cases’ final exercise session or three 141 
months after their initial donation for controls. 142 
Sperm and blood processing 143 
Subjects gave resting preprandial sperm and blood donations before and after the 144 
three month exercise intervention. Following an overnight fast, subjects extracted 145 
their sperm by masturbating at home and donated their sample to the researchers at 146 
the University within 30 min of extraction. All sperm donations and analyses were 147 
performed according the World Health Organization’s recommendations. Sperm cell 148 
number and vitality was assessed by the same researcher using a sheep-counter. 149 
Mature, motile sperm were isolated from lymphocytes, epithelial cells, immature or 150 
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abnormal sperm and other cellular debris using the PureSperm 40/80 reagents 151 
(Nidacon). Briefly, 2 ml of PureSperm 40 was carefully layered on top of PureSperm 152 
80, followed by gently aliquoting 1.5 ml of ejaculate onto the density gradient. The 153 
density gradient was spun at 300 G for 20 min. The mature sperm were pelleted and 154 
supernatant was removed. The pellet was washed twice by resuspending it in 5 ml of 155 
PBS before being spun at 500 G for 10 min. DNA was extracted from mature sperm 156 
suspended in 200 µl of PBS using the Purelink Genomic DNA Mini kit 157 
(LifeTechnologies) following the manufacturer’s recommendations with some small 158 
adjustments. To deform the tightly packaged DNA in mature sperm, 0.03 mmol of 159 
DL-Dithiothreitol solution (Sigma-Aldrich) was added to the sample before the 160 
addition of proteinase K solution and the protein digestion step (incubation at 55°C) 161 
was extended from the recommended 10 min to 90 min. All extractions were 162 
performed immediately after sperm donation to prevent any temporal de novo 163 
influences on DNA methylation. DNA yield was assessed using the Nanodrop 2000 164 
Spectrophotometer (Thermo Scientific) before being stored at -20°C. 165 
A preprandial blood sample (24 ml) was drawn from the antecubital vein into serum 166 
separating tubes with the subject seated, using standard phlebotomy procedures. 167 
Blood was immediately stored on ice before further processing. Blood lipid assays 168 
were performed as described previously [25].  169 
Global DNA methylation analysis 170 
Average global DNA methylation of sperm from all subjects was quantified using the 171 
5-mC ELISA Kit (Zymo Research, USA). All experiments were performed according 172 
to the manufacturer’s procedures. All paired samples before and after the 173 
intervention were run on the same plate, as well as 100% methylated and 0% 174 
methylated controls, all run in duplicate with a standard curve. Absorbance was 175 
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measured at 450 nm using the Multiskan FC Microplate Photometer (Thermo 176 
Scientific, Australia) and average DNA methylation was calculated using the formula 177 
generated from the standard curve. The average intra-assay coefficient of variation 178 
for duplicate samples was 4.85%. 179 
Genome-wide DNA methylation analysis 180 
Genome-wide sperm DNA methylation was quantified in 12 cases before and after 181 
the exercise intervention using the Infinium HumanMethylation 450K BeadChip 182 
(Illumina) as previously described [25]. Experiments were conducted following the 183 
manufacturer’s guidelines, with the help of the Busselton Population Medical 184 
Research Institute. Briefly, raw β-values underwent Subset-quantile Within Array 185 
Normalization (SWAN) and were transformed to M-values using the logit function 186 
(log2 (β/(1- β))) before analyzing differentially methylated CpG sites after exercise 187 
training. M-values were converted to β-values for representation of differentially 188 
methylated CpG sites in tables and graphs because they correspond to the 189 
percentage of CpG methylation and are a good biologically relevant representation. 190 
Genome-wide DNA methylation data was analyzed using Partek (Genomic Suite, 191 
version 6.6). 192 
Exercise training 193 
Subjects were randomly allocated to either an exercise training (cases) or control 194 
group. Cases completed sprint interval training twice weekly for three months. Three 195 
months of exercise training was chosen because it covered one human 196 
spermatogenesis cycle. The controls did not engage in any form of training but were 197 
asked not to deviate from their routine physical activity habits. All subjects were 198 
asked to adhere to their normal diet. The sprint interval training schedule is outlined 199 
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in Table 2. Sprint interval training is an effective type of exercise training that rapidly 200 
improves cardiorespiratory fitness and endurance performance [30-33].  201 
The exercise training protocol of this study was based on research shown to improve 202 
cardiorespiratory fitness and endurance performance [25, 34], but with some 203 
adjustments, to avoid overuse injuries that could occur with an extended training 204 
period (three months). Subjects completed 30 s sprints at maximal intensity with a 205 
passive four minute rest period between efforts. Training began with three sprints 206 
and was progressed by one effort every fortnight until week 7, when sprints were 207 
kept at six efforts for the remaining six weeks of the intervention. Before each 208 
session, subjects completed a short warm-up entailing a light 5 min jog, dynamic 209 
stretches and some 20 m sprints at 70, 80, 90 and 100% of maximal effort. Training 210 
was performed on the University’s athletics oval and subjects were supervised and 211 
given constant encouragement during sprints by an Exercise Physiologist. 212 
Statistical analyses 213 
Kolmogorov-Smirnov and Shapiro-Wilks were performed to assess normality. Two-214 
tailed paired t-tests were used to assess within-subject changes to physical, health 215 
and fitness variables. A repeated measures ANOVA was used to determine the 216 
interaction between global sperm DNA methylation before and after the intervention 217 
in relation to cases and controls using IBM SPSS for Windows (version 21). 218 
Differentially methylated CpG sites in cases were determined by repeated measures 219 
ANOVA using Partek (Genomic Suite, version 6.6). In order to control for false 220 
positives, a false discovery rate correction (FDR, q≤0.1) was applied to genome-wide 221 
data by converting p-values to q-values. Hierarchical clustering, gene ontology and 222 
pathway analysis on genome-wide CpG methylation data were performed using 223 
Partek (Genomic Suite, version 6.6). Disease annotation analysis was conducted 224 
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using the Database for Annotation, Visualization and Integrated Discovery (DAVID, 225 
version 6.7). Statistical significance was set at p<0.05. 226 
 227 
Results  228 
Exercise training improved cardiorespiratory fitness 229 
To determine whether exercise training alters human sperm DNA methylation, 13 230 
untrained male volunteers completed three months of exercise training using a 231 
modified training protocol (Table 2) previously shown to improve cardiorespiratory 232 
fitness and induce genome-wide DNA methylation changes in leukocytes [25]. 233 
Although V̇O2max was unchanged (2.2%, p=0.35), relative to baseline, the cases, on 234 
average, had a significantly lower resting heart rate by 10 beats.min-1 and completed 235 
an extra one min at a significantly higher maximal treadmill speed (p=0.01 and 236 
p=0.002, respectively), while controls showed no significant changes in these 237 
variables (Table 1).  238 
To assess whether exercise training influences average sperm DNA methylation, we 239 
assessed global sperm DNA methylation in cases and controls using ELISA-based 240 
chemistry. After adjusting for ELISA plate, relative to the unchanged global sperm 241 
DNA methylation observed in controls (n=11, 4.09%), sperm DNA was significantly 242 
de-methylated after three months of exercise training (n=13, -6.63%, interaction 243 
p=0.006) (Figure 1A and B). 244 
Based on the global DNA methylation results we only quantified genome-wide sperm 245 
DNA methylation in 12 cases before and after three months of exercise training 246 
using the 450K BeadChip (Illumina). After applying a FDR (q≤0.1), we found DNA 247 
methylation changes occurred throughout the genome in relation to the nearest gene 248 
and CpG islands (Figure 1C and D). Of these, 7509 CpG sites relating to 4602 249 
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genes had significant DNA methylation changes ranging from 0.3 to 6.2% after 250 
exercise training (Figure 1E and 2). More CpG sites were demethylated rather than 251 
methylated after exercise training (4275 vs 3233, respectively). The top 25 252 
methylated and demethylated CpG sites after exercise training are outlined in Table 253 
3. 254 
To gain insight into the biological impact of the CpG methylation changes following 255 
exercise, we performed gene ontology and pathway analysis. Genes with altered 256 
CpG methylation were those enriched for crucial biological processes including 257 
developmental process, anatomical structure, embryonic morphogenesis and organ 258 
development (Figure 3 and Supplementary Table 1). Pathway analysis revealed 259 
genes with CpG site DNA methylation changes were enriched for pathways such as 260 
MAPK signaling, PI3K-Akt signaling, pathways in cancer and ErbB signaling (Table 261 
4).  262 
In the search for the most biologically relevant CpG methylation changes, we 263 
focused on CpG sites with a ≥1.5% increase (n=703) or decrease (n=1247) in 264 
methylation after exercise training and entered them into DAVID for disease 265 
annotation analysis. While genes with demethylated CpG sites were those relating to 266 
normal variation, those with increased methylation were enriched for numerous 267 
diseases, with the most overrepresented diseases being Schizophrenia, Parkinson’s 268 
Disease, autism, cervical cancer and leukemia (Figure 4).  269 
The global erasure of sperm CpG methylation that occurs after fertilization is well 270 
established [35-37]. The sperm CpG methylation at imprinted genes, however, are 271 
resistant to the global erasure after fertilization [38, 39] and as such, these genes are 272 
key candidates for possible transgenerational inheritance through sperm. We found 273 
16 paternally imprinted genes were differentially methylated after the three month 274 
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exercise training intervention (Table 5), in genes associated with pathologies 275 
including EKG abnormalities (KCNQ1OT1 and KCNQ1), autism and alcohol 276 
dependence (GABRG3), Tourette syndrome, obsessive compulsive disorder and 277 
dystonia (SGCE), and Alzheimer’s disease, obesity, type 2 diabetes mellitus, blood 278 
pressure and atherosclerosis (IGF2 and INS-IGF2).  279 
 280 
Discussion 281 
Unlike the genome, the epigenome is malleable to changing environments and these 282 
changes are somewhat heritable [3, 4]. Germ cells (sperm and oocytes) are likely 283 
vectors that transfer environmentally-affected DNA methylation profiles to future 284 
generations. We are the first to show the exercise training-induced DNA methylation 285 
changes in human sperm. We found exercise training significantly manipulated 286 
genome-wide DNA methylation and most strikingly, increased methylation in 287 
disease-associated genes indicating transcriptional silencing. Moreover, methylation 288 
changes occurred in paternally imprinted genes that are exempt from the DNA 289 
methylation erasure after fertilization [38, 39]. 290 
Mounting evidence has demonstrated the capacity of exercise training to influence 291 
the human DNA methylome in numerous tissues, including skeletal myocytes [26-292 
28], adipocytes [29] and leukocytes [25]. Exercise training or increased physical 293 
activity tends to be associated with a reduced level of somatic cell global DNA 294 
methylation. Leukocyte DNA methylation was anti-correlated to levels of physical 295 
activity in 509 older adults (>70 y) [40] and we previously reported more 296 
demethylated leukocyte CpG sites in response to a four week exercise training 297 
intervention in young men [25]. Furthermore, global and gene-specific demethylation 298 
occurred after acute exercise in human skeletal myocytes [41]. In the present study, 299 
 13 
we found global sperm DNA methylation was reduced after three months of exercise 300 
training, suggesting that exercise may systemically demethylate both somatic and 301 
germ cells. Interestingly, older adults have more heavily methylated global sperm 302 
DNA compared to their younger counterparts [23, 42]. Also defective human sperm 303 
exhibit nearly two-fold higher levels of global DNA methylation [43]. To that end, the 304 
global demethylation observed in our subjects after exercise training could be 305 
favorable, possibly counteracting the increased DNA methylation associated with 306 
ageing. This, in turn, could positively influence fertility though future studies are 307 
necessary. 308 
Interestingly, exercise training was associated with sperm methylation changes to 309 
CpG sites in genes related to pathways and biological processes similar to those 310 
observed in skeletal muscle [26] and leukocytes [25] from previous studies. For 311 
example, pathways regulated by exercise training-induced leukocyte DNA 312 
methylation alterations [25] that were also observed in sperm include MAPK 313 
signaling, PI3K-Akt signaling and pathways in cancer. Similarly, overlapping 314 
pathways between skeletal muscle [26] and sperm pathways modulated by exercise 315 
training include MAPK signaling, insulin signaling and ErbB signaling. Therefore, it 316 
would seem that some exercise-responsive genes (CpG sites) are regulated by DNA 317 
methylation in human somatic cells and also in sperm. 318 
The genes with CpG methylation changes in the present study were enriched for 319 
numerous molecular and cellular processes including anatomical structure 320 
development and morphogenesis, single-organism development and embryonic 321 
morphogenesis. Genes with exercise-induced CpG methylation changes were also 322 
associated with many debilitating diseases such as Schizophrenia, Parkinson’s 323 
disease, cervical cancer, leukemia and autism. The genes associated with diseases 324 
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were methylated after exercise training, indicating that these genes may have been 325 
transcriptionally silenced. Age-associated sperm CpG methylation patterns were 326 
observed in genes implicated in Schizophrenia in humans [23] and mice [24]. Some 327 
of the adverse DNA methylation patterns found in sperm of aged mice was 328 
transmitted to the brain of their offspring, leading to transcriptional dysregulation of 329 
genes involved in schizophrenia and autism, facilitating the disease-related traits 330 
[24]. Furthermore, offspring (F1 to F3) of gestating female rats treated with endocrine 331 
disruptors (bisphenol-A, bis[2-ethlhexyl]phthalate and dibutyl phthalate and 332 
vinclozolin) have altered sperm DNA methylation and an increased risk of testis 333 
disease, obesity and infertility [15, 44, 45]. These environmentally-induced DNA 334 
methylation aberrations led to transcriptional changes in common pathways across 335 
numerous somatic cells, including those regulated in the present study (MAPK 336 
signaling, insulin signaling and pathways in cancer) [46]. Whether the altered sperm 337 
DNA methylation observed in our subjects will be transmitted to their offspring and 338 
prevent the development of disease is speculative and would require large human 339 
studies involving the analysis of multiple generations.  340 
Germ cells undergo global demethylation following fertilization [35, 39]. 341 
Consequently, the likelihood of such CpG methylation changes surviving this 342 
demethylation event is uncertain. We did, however, reveal a number of paternally 343 
imprinted genes (e.g. IGF2, INS-IGF2, SGCE and GABRG3) had differentially 344 
methylated CpGs after exercise training. These genes are exempt from the global 345 
demethylation after fertilization [38, 39] and as such, are key candidates for exercise-346 
induced transgenerational inheritance of DNA methylation gene programming. Our 347 
disease analysis using DAVID revealed the differentially methylated paternally 348 
imprinted genes after exercise training were related to neurological disorders 349 
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(autism, Alzheimer’s disease, Tourette’s syndrome and obsessive compulsive 350 
disorder) and cardio-metabolic diseases (obesity, type 2 diabetes mellitus, high 351 
blood pressure and atherosclerosis). Whilst no evidence exists, it is tempting to 352 
speculate that exercise training may remodel the sperm methylome and that this 353 
epigenetic modification may reduce the disease risk of offspring. 354 
DNA methyltransferase enzymes (DNMT1, DNMT3A, DNMT3B and DNMT3L) as 355 
well as ten-eleven translocation (TET1, TET2 and TET3) proteins could be 356 
modulated by exercise training leading to altered DNA methylation. Our study was 357 
not designed to target the exact physiological or molecular mechanism by which 358 
exercise training influences DNA methylation in sperm, rather it was designed to 359 
investigate whether exercise training influences sperm DNA methylation. Therefore, 360 
further research is required to identify the molecular mechanisms evoking the 361 
changes in the sperm methylome after exercise training. 362 
Our study has several limitations. Firstly, our study had a modest sample size and 363 
there was a statistically different global sperm DNA methylation between cases and 364 
controls at baseline. While we acknowledge this is not desirable, our statistical 365 
analysis accounted for the observed difference.  We do, however, recommend that 366 
our results should be verified in a larger population. The relative exercise workload 367 
was not standardized. We did, however, ask that all subjects perform each sprint 368 
maximally without pacing to ensure they are working at maximal intensity. Certain 369 
diets are associated with DNA methylation levels in somatic cells [47, 48]. Despite 370 
asking our subjects not to deviate from their routine dietary habits, the lack of control 371 
for diet in our study should also be acknowledged. Finally, we did not control for 372 
genotype-DNA methylation interactions or quantify DNA methylation in context with 373 
other epigenetic modifications or gene expression. Nonetheless, our novel finding 374 
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that exercise alters human sperm DNA methylation should encourage future 375 
investigations into the influence of exercise training on germ cell epigenetic 376 
modifications and gene regulation.  377 
 378 
Conclusions 379 
We report for the first time that exercise training significantly modifies the human 380 
sperm methylome. Whilst exercise training was associated with an increased global 381 
sperm demethylation overall, methylation in key genes associated with human 382 
disease was increased indicating transcriptional silencing of these genes.  383 
 384 
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Figure Legends 537 
Figure 1. Sperm DNA methylation changes after exercise training. Average 538 
percent (±SE) of global sperm DNA methylation is given for 13 cases (A) and 11 539 
controls (B) after the three month intervention. Relative to the controls who showed 540 
no global methylation change, cases exhibited a global demethylation (-6.63%) after 541 
three months of exercise training (mean±SE: 39.1±3.85 to 43.2±3.6 and 52.95±3.56 542 
to 46.3±3.4, respectively, interaction p=0.006). Data are from repeated measures 543 
ANOVA adjusting for ELISA plate number. Genome-wide DNA methylation changes 544 
at CpG sites in relation to the nearest gene (C) and CpG islands (D) are shown. Data 545 
are from Chi2 tests. E) The number of CpG sites with increased methylation (black 546 
bars) and decreased methylation (grey bars) are given on the y-axis with the 547 
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magnitude of change illustrated on the x-axis. Data are from differentially methylated 548 
CpG sites (q≤0.1).  549 
 Figure 2. Hierarchical clustering of CpG sites after three months of exercise 550 
training. The CpG methylation status is indicated by blue (low methylation) and 551 
yellow (high methylation) from 12 subjects before (grey bar) and after (purple bar) 552 
three months of exercise training. Each branch of the array tree on the left of the 553 
purple and grey bars are subjects. The array tree at the top of the hierarchical cluster 554 
indicates clusters of CpG sites modified by exercise training. Data are from 555 
differentially methylated CpG sites (q≤0.1). 556 
 Figure 3. Gene ontology for genes with differentially methylated CpG sites 557 
after exercise training. Genes with altered CpG site methylation after exercise are 558 
grouped for function on the y-axis with corresponding enrichment scores on the x-559 
axis. Data are from differentially methylated CpG sites (q≤0.1). 560 
Figure 4. Disease annotation analysis for genes with differentially methylated 561 
CpG sites after exercise training. Data are from genes with a ≥1.5% increase or 562 
decrease in methylation after exercise training (q≤0.1). The y-axis represents the 563 








Table 1.  Participant characteristics before and after three months of exercise training. 








 Before After 
Age (y) 24.4±5.19  22.45±4.74 
Ht (cm) 181.1±6.54  177.95±4.07 
Wt (kg) 83.58±10.7 84.01±11.97  82.22±11.83 82.93±10.64 
BMI (Wt/Ht2) 25.53±3.34 25.89±3.61  25.94±3.5 25.9±3.08 
HR (beats.min-1) 78.54±15.64 68.23±7.15*  68.18±11.58 66.45±8.19 
SBP (mm Hg) 130.46±11.82 129.85±10.64  123.45±9.2 123.09±10.24 
DBP (mm Hg) 77.23±9.87 76.38±7.85  75.82±8.51 72.27±7.14 
CSBP (mm Hg) 110.92±9.86 111.08±8.43  106.91±8.38 105.72±9.32 
CDBP (mm Hg) 76.08±17.35 77.69±7.77  76.36±8.64 73.64±7.38 
Aix (%) -4.15±9.73 -4.15±8.73  -2.36±12.8 -1.18±11.71 
Cholesterol 
(mmol/l)^ 
4.82±0.88 4.77±1.04  4.01±1.0 3.97±0.77 
Triglyceride 
(mmol/l)^ 
1.01±0.48 1.07±0.46  0.9±0.38 0.82±0.18 
HDLC (mmol/l)^ 1.43±0.25 1.43±0.3  1.37±0.2 1.29±0.14 
LDLC (mmol/l)^ 2.92±0.79 2.87±0.88  2.22±0.75 2.32±0.74 
Glucose (mmol/l)^ 4.78±0.38 5.22±0.52  4.9±0.46 4.92±0.31 
Insulin (mmol/l)^ 6.94±2.72 10.72±6.44  7.15±3.65 12.78±16.42 
?̇?O2max (ml.kg.min-1) 47.43±5.64 48.47±6.0  45.85±7.34 44.92±5.49 
Maximal treadmill 
speed (km.h-1) 
14.4±1.12 14.9±1.11**  14.07±1.52 13.84±1.8 
Sperm volume (ml) 4.7±1.4 5.17±0.87  3.95±1.7 3.97±1.79 
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 571 
Legend: Ht, height; Wt, weight; BMI, body mass index; HR, resting heart rate; SBP, 572 
systolic blood pressure; DBP, diastolic blood pressure; CSBP, central (aortic) blood 573 
pressure; CDBP, central (aortic) diastolic blood pressure; augmentation index; 574 
HDLC, high-density lipo-protein cholesterol; LDLC, low-density lipoprotein 575 
cholesterol; V̇O2max, maximal oxygen uptake; ^, n=8; #, number; %, percentage. Data 576 
are from two-tailed paired t-test and expressed as mean±SD. Sperm analysis was 577 
conducted on semen samples and not from highly motile sperm isolated using the 578 





























Sperm alive (%) 61.65±24.42 62.72±13.77  48.26±23.26 53.89±14.14 
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Table 2. Description of the three month exercise program.  592 
Week Session # Training load* Training sprint time (min) Total session time (min) 
1 1 3 sprints 1.5 9.5 
 
2 3 sprints 1.5 9.5 
2 3 3 sprints 1.5 9.5 
 
4 3 sprints 1.5 9.5 
3 5 4 sprints 2 14 
 
6 4 sprints 2 14 
4 7 4 sprints 2 14 
 
8 4 sprints 2 14 
5 9 5 sprints 2.5 18.5 
 10 5 sprints 2.5 18.5 
6 11 5 sprints 2.5 18.5 
 12 5 sprints 2.5 18.5 
7 13 6 sprints 3 23 
 14 6 sprints 3 23 
8 15 6 sprints 3 23 
 16 6 sprints 3 23 
9 17 6 sprints 3 23 
 18 6 sprints 3 23 
10 19 6 sprints 3 23 
 20 6 sprints 3 23 
11 21 6 sprints 3 23 
 22 6 sprints 3 23 
12 23 6 sprints 3 23 
 24 6 sprints 3 23 
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  Total Time 120 60 454 
Legend: # number; * all sprints were completed at maximum intensity, separated by a four 593 
minute passive recovery.594 
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Table 3. DNA methylation changes after three months of exercise training (q≤0.1). 595 
Location in relation to  DNA methylation (%)   
     











Δ p-value q-value 
(≤0.1) 
cg02598618 - - Open 
sea 
10 94.0±1.4 98.6±1.1 4.6 1.79×10-5 0.06 
cg02655397 - - N shelf 11 80.7±4.4 85.1±3.3 4.5 0.0005 0.08 
cg10243075 CACNA1A Body N shore 19 23.2±3.6 27.6±5.0 4.4 0.0004 0.08 
cg27222157 RBM14 TSS1500 N shore 11 22.2±6.8 26.5±8.5 4.4 0.0009 0.08 
cg10413297 RFPL3S TSS1500 Open 
sea 
22 25.6±6.7 29.7±6.6 4.1 0.001 0.09 
cg16533336 WBSCR17 Body Open 
sea 
7 76.7±2.6 80.8±2.3 4.1 1.17×10-7 0.02 
cg09194930 MT1L TSS200 Island 16 14.7±9.5 18.8±12.7 4.1 0.001 0.09 
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cg00685853 - - N shore 2 14.4±3.9 18.4±6.2 4.0 0.0001 0.07 
cg27205941 GMDS TSS200 Island 6 29.0±4.1 32.9±3.5 4.0 0.001 0.09 
cg17745251 C10orf140 Body Island 10 25.0±2.7 29.0±3.0 4.0 0.002 0.09 
cg25485435 RAMP1 TSS1500 N shore 2 16.9±3.5 20.8±3.0 3.9 0.0002 0.07 
cg11888420 - - Open 
sea 
6 33.0±2.7 36.8±4.6 3.8 0.001 0.09 
cg08715827 - - Open 
sea 
12 6.1±2.3 9.8±5.8 3.8 0.001 0.09 
cg15617548 GORASP2 5'UTR 
1stExon 
Island 2 23.5±2.8 27.1±2.8 3.7 0.0009 0.08 




3 23.9±11.9 27.5±12.8 3.7 0.002 0.097 
cg17271592 HIST2H2AA4 
HIST2H2AA3 
TSS1500 Island 1 13.8±3.1 17.4±2.6 3.6 0.0006 0.08 
cg06785129 RFPL3 TSS1500 Open 
sea 









Island 6 33.7±2.2 37.3±2.9 3.6 0.002 0.09 
cg13916261 FNBP1 Body N shelf 9 24.4±3.9 27.9±4.9 3.5 0.0003 0.08 
cg09303484 - - Open 
sea 
7 63.3±4.3 66.8±3.6 3.5 0.0008 0.08 
cg05528975 - - Open 
sea 
2 25.9±2.5 29.4±3.1 3.5 0.0005 0.08 
cg17627829 HCG18 Body N shore 6 9.5±3.4 13.0±4.1 3.5 0.002 0.09 




X 8.8±2.7 12.3±4.4 3.5 0.002 0.09 
cg20681184 PIK3CD 5'UTR S shore 1 14.5±2.8 18.0±4.5 3.5 0.002 0.09 
cg15069995 HORMAD1 5'UTR Open 
sea 
1 5.9±2.1 9.3±3.9 3.4 0.0009 0.08 
cg13062455 SEL1L Body Open 14 88.2±2.3 85.4±3.3 -2.9 1.27×10-5 0.05 
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sea 
cg24360197 - - Open 
sea 
15 70.1±8.4 67.2±7.9 -2.9 0.001 0.09 




X 87.7±4.1 84.7±.5 -3.0 0.0009 0.08 
cg24121979 - - Open 
sea 
12 94.9±3.2 91.9±2.0 -3.0 0.0003 0.08 
cg20909579 PDE6B TSS1500 
Body 





S shore 5 54.9±8.4 51.9±8.4 -3.0 0.001 0.09 
cg27569203 CELSR1 Body Island 22 90.2±2.4 87.3±1.6 -3.0 0.002 0.09 
cg26235273 DKK3 3'UTR Open 
sea 
11 71.0±4.0 67.8±3.8 -3.1 0.0006 0.08 
cg17518550 C1orf150 TSS200 Open 
sea 
1 82.3±4.0 79.2±6.4 -3.1 0.001 0.09 
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cg16514287 SLC25A36 Body Open 
sea 
3 94.0±1.4 90.8±1.1 -3.1 1.7×10-6 0.03 
cg26057840† - - N shore 20 89.4±2.7 86.2±2.6 -3.2 0.0005 0.08 
cg24544876 - - S shore 5 78.3±3.3 75.1±2.5 -3.2 0.0008 0.08 
cg14630692 URM1 Body Open 
sea 
9 86.4±1.7 83.2±2.4 -3.2 0.001 0.09 
cg03440485 - - Island X 22.9±2.3 19.7±2.1 -3.2 0.001 0.09 
cg15832577‡ C1orf53 Body S shore 1 78.6±2.5 75.3±3.2 -3.3 0.0002 0.07 







22 92.5±14.5 89.0±19.1 -3.5 0.0005 0.08 
cg11342670 KIAA0319 Body Open 
sea 
6 78.9±9.3 75.5±10.3 -3.5 0.001 0.09 
cg03987985 L1TD1 3'UTR Open 
sea 
1 75.6±4.6 72.0±5.6 -3.6 0.001 0.09 











Data are expressed are beta values ± standard deviation. 605 
Legend: Chr, chromosome number; Δ, difference; 3’, three prime; 5’, five prime; UTR, untranslated region; TSS1500, 1500 bases 606 
upstream of transcription start site; TSS200, 200 bases upstream of transcription start site; *DMR, differentially methylated region; 607 
†CDMR, cancer differentially methylated region; ‡RDMR, reprogrammed differentially methylated region.608 
RB1 Body sea 
cg17486639 - - N shelf 19 89.8±1.6 86.0±3.1 -3.8 0.0006 0.08 
cg03834767 CDK14 3'UTR Open 
sea 
7 90.6±2.0 86.4±6.0 -4.1 0.002 0.09 
cg16631698 - - Island 10 81.7±4.2 77.2±2.3 -4.5 0.002 0.09 
cg08269188 CBX5 5'UTR Open 
sea 
12 83.7±2.7 79.0±4.5 -4.7 5.17×10-5 0.06 
cg05946920 GGA1 Body Island 22 39.7±6.7 33.6±3.4 -6.2 0.002 0.096 
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Table 4. Molecular pathways related to genes with differentially methylated CpG 609 
sites after exercise training (p≤0.05). 610 





Circadian entrainment  8.0 0.0003 24 kegg pathway 51 
Axon guidance 7.2 0.001 29 kegg pathway 176 
Endocytosis 7.0 0.001 39 kegg pathway 211 
Glutamatergic synapse 6.1 0.002 25 kegg pathway 182 
Protein digestion and 
absorption 
5.9 0.003 22 kegg pathway 46 
ECM-receptor interaction 5.4 0.004 19 kegg pathway 41 
GABAergic synapse 4.7 0.01 22 kegg pathway 133 
Bile secretion 4.4 0.01 18 kegg pathway 74 
MAPK signaling pathway 4.4 0.01 41 kegg pathway 119 
Focal adhesion 4.3 0.01 34 kegg pathway 5 
PI3K-Akt signaling pathway 4.3 0.01 54 kegg pathway 45 
Huntington's disease 4.3 0.01 33 kegg pathway 53 
Transcriptional misregulation 
in cancer 
4.3 0.01 31 kegg pathway 94 
African trypanosomiasis 4.1 0.02 10 kegg pathway 69 
Colorectal cancer 4.1 0.02 13 kegg pathway 148 
Viral myocarditis 3.9 0.02 15 kegg pathway 105 
Taurine and hypotaurine 
metabolism 
3.7 0.02 4 kegg pathway 195 
Galactose metabolism 3.7 0.03 8 kegg pathway 15 
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Long-term depression 3.6 0.03 12 kegg pathway 250 
Endocrine and other factor-
regulated calcium 
reabsorption 
3.6 0.03 10 kegg pathway 258 
Retrograde endocannabinoid 
signaling 
3.6 0.03 21 kegg pathway 129 
Glycosaminoglycan 
biosynthesis - chondroitin 
sulfate / dermatan sulfate 
3.4 0.03 7 kegg pathway 248 
Nicotine addiction 3.4 0.03 10 kegg pathway 62 
Allograft rejection 3.4 0.03 10 kegg pathway 177 
Selenocompound 
metabolism 
3.4 0.04 5 kegg pathway 135 
Morphine addiction 3.2 0.04 20 kegg pathway 86 
Amoebiasis 3.2 0.04 21 kegg pathway 56 
Graft-versus-host disease 3.1 0.04 10 kegg pathway 209 
Maturity onset diabetes of 
the young 
3.1 0.04 7 kegg pathway 241 
Pathways in cancer 3.1 0.05 49 kegg pathway 128 
ErbB signaling pathway 3.1 0.05 15 kegg pathway 121 
Type I diabetes mellitus 2.9 0.05 10 kegg pathway 242 
Insulin secretion 2.9 0.05 17 kegg pathway 4 
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Table 5. Paternally imprinted gene CpG methylation changes caused by exercise training. 611 
 Location in relation to  DNA methylation (%)   
     









Δ p-value q-value 
(≤0.1) 
GRB10 cg12358041 5'UTR 
Body 
Open sea 7 92.3±1.2 91.0±1.2 -1.3 0.0004 0.08 
 cg26050906 5'UTR 
TSS200 










S shore 7 10.5±2.0 13.5±4.5 3.0 0.0006 0.08 
DLGAP2 cg27316067 Body S shore 8 64.3±11.2 62.2±11.3 -2.1 0.002 0.09 
SFMBT2 cg15362304 Body S shelf 10 93.4±1.1 92.5±1.1 -0.9 0.0007 0.08 



















Open sea 11 95.5±1.0 94.1±1.0 -1.4 0.001 0.09 
SLC38A4 cg12152384 Body Open sea 12 93.4±1.0 92.3±0.9 -1.1 0.002 0.09 
WIF1 cg15862358 TSS1500 S shore 12 6.7±2.6 8.6±5.5 1.9 0.001 0.09 
DLK1 cg17412258 TSS1500 CpG island 14 2.0±0.5 2.8±0.6 0.8 0.0005 0.08 









N shore 14 93.0±0.9 
 
91.8±1.0 -1.2 0.002 0.10 
GABRG3 cg08325929 Body S shelf 15 86.2±2.5 84.9±2.7 -1.3 0.003 0.10 
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Data are expressed are beta values ± standard deviation. 612 
Legend: Chr, chromosome number; Δ, difference; 3’, three prime; 5’, five prime; UTR, untranslated region; TSS1500, 1500 bases upstream of 613 
transcription start site; TSS200, 200 bases upstream of transcription start site; *DMR, differentially methylated region; ‡RDMR, reprogrammed 614 
















CpG island 20 4.0±1.0 5.6±2.2 1.6 0.002 0.10 
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Supplementary Table 1. Gene ontology for genes with DNA methylation changes after exercise training (q≤0.1). 626 
Function Type Enrichment  
score 
 p-value q-value 
 
# genes  Go ID 
Single-organism 
process 
BP 34.82 7.57×10-16 3.88×10-12 1428 44699 
Single-organism cellular 
process 
BP 26.32 3.70×10-12 9.50×10-9 1251 44763 
Biological process BP 23.74 4.89×10-11 8.22×10-8 1968 8150 
Cellular process BP 23.47 6.41×10-11 8.22×10-8 1678 9987 
Developmental process BP 21.96 2.89×10-10 2.97×10-7 591 32502 
Biological regulation BP 19.53 3.31×10-9 2.83×10-6 1227 65007 
Regulation of biological 
process 
BP 18.66 7.88×10-9 5.78×10-6 1168 50789 
Anatomical structure 
development 
BP 18.31 1.12×10-8 7.18×10-6 374 48856 
Anatomical structure 
morphogenesis 




BP 17.46 2.62×10-8 1.29×10-5 312 48869 
Regulation of cellular 
process 
BP 17.38 2.84×10-8 1.29×10-5 1113 50794 
Single-organism 
developmental process 
BP 17.32 3.01×10-8 1.29×10-5 405 44767 
Ras guanyl-nucleotide 
exchange factor activity 
MF 17.22 3.32×10-8 1.31×10-5 36 5088 
Guanyl-nucleotide 
exchange factor activity 
MF 17.04 3.97×10-8 1.45×10-5 50 5085 




MF 15.66 1.58×10-7 4.68×10-5 182 3700 
Pattern specification 
process 
BP 15.65 1.60×10-7 4.68×10-5 84 7389 




Small gtpase regulator 
activity 
MF 15.52 1.82×10-7 4.68×10-5 71 5083 




MF 15.47 1.91×10-7 4.68×10-5 97 60589 
Multicellular organismal 
process 
BP 14.95 3.22×10-7 7.51×10-5 435 32501 
Embryonic 
morphogenesis 
BP 14.90 3.37×10-7 7.51×10-5 81 48598 
Single-multicellular 
organism process 
BP 14.75 3.91×10-7 8.37×10-5 428 44707 
Molecular function MF 14.47 5.18×10-7 0.0001 2015 3674 
Regulation of cell 
communication 
BP 14.16 7.09×10-7 0.0001 319 10646 
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Regulation of signaling BP 14.14 7.22×10-7 0.0001 318 23051 
Regulation of cell 
development 
BP 13.86 9.59×10-7 0.0002 124 60284 
Cell junction CC 13.47 1.42×10-6 0.0003 136 30054 
Sequence-specific DNA 
binding 
MF 13.17 1.90×10-6 0.0003 127 43565 
Binding MF 12.88 2.55×10-6 0.0004 1597 5488 
Cell differentiation BP 12.46 3.88×10-6 0.0006 218 30154 
Regulation of 
neurogenesis 
BP 12.44 3.96×10-6 0.0006 80 50767 
Regionalization BP 12.19 5.08×10-6 0.0008 53 3002 
Regulation of nervous 
system development 
BP 12.16 5.24×10-6 0.0008 87 51960 
Negative regulation of 
cell differentiation 
BP 11.75 7.85×10-6 0.001 88 45596 
Cellular response to 
stimulus 
BP 11.54 9.69×10-6 0.001 653 51716 
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Extracellular matrix CC 11.31 1.22×10-5 0.002 65 31012 
Regulation of neuron 
differentiation 
BP 11.27 1.28×10-5 0.002 67 45664 
Motor activity MF 11.21 1.35×10-5 0.002 34 3774 
Extracellular matrix part CC 11.21 1.35×10-5 0.002 44 44420 
Organ development BP 11.20 1.37×10-5 0.002 159 48513 
Positive regulation of 
cellular process 
BP 11.08 1.55×10-5 0.002 471 48522 
Regulation of cell 
differentiation 
BP 10.78 2.08×10-5 0.002 174 45595 
Negative regulation of 
developmental process 
BP 10.76 2.12×10-5 0.002 103 51093 
Positive regulation of 
cellular biosynthetic 
process 
BP 10.76 2.13×10-5 0.002 210 31328 
Dendritic spine CC 10.73 2.19×10-5 0.002 18 43197 
Synaptic transmission BP 10.72 2.22×10-5 0.002 81 7268 
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Neuron part CC 10.65 2.36×10-5 0.002 105 97458 
System development BP 10.60 2.50×10-5 0.003 115 48731 
Response to external 
stimulus 
BP 10.57 2.57×10-5 0.003 168 9605 
Synapse part CC 10.35 3.21×10-5 0.003 71 44456 
Cell communication BP 10.34 3.22×10-5 0.003 148 7154 
Signal transduction BP 10.33 3.26×10-5 0.003 538 7165 
Axon guidance BP 10.31 3.32×10-5 0.003 68 7411 
Negative regulation of 
neuron differentiation 
BP 10.15 3.91×10-5 0.003 18 45665 
Neuron spine CC 10.15 3.91×10-5 0.003 18 44309 
Cation binding MF 10.14 3.94×10-5 0.003 581 43169 
Metal ion binding MF 10.07 4.23×10-5 0.004 572 46872 
Positive regulation of 
biosynthetic process 
BP 10.06 4.26×10-5 0.004 211 9891 
Positive regulation of 
macromolecule 
BP 10.05 4.33×10-5 0.004 196 10557 
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biosynthetic process 
Regulation of signal 
transduction 
BP 10.04 4.38×10-5 0.004 271 9966 
Phospholipid binding MF 9.97 4.66×10-5 0.004 93 5543 
Ion channel activity MF 9.89 5.05×10-5 0.004 73 5216 
Anterior/posterior 
pattern specification 
BP 9.83 5.40×10-5 0.004 36 9952 
Substrate-specific 
channel activity 
MF 9.68 6.24×10-5 0.005 74 22838 
Rho guanyl-nucleotide 
exchange factor activity 
MF 9.61 6.69×10-5 0.005 22 5089 
Negative regulation of 
signal transduction 
BP 9.56 7.04×10-5 0.005 110 9968 
Cell part CC 9.55 7.10×10-5 0.005 1907 44464 
Negative regulation of 
response to stimulus 
BP 9.48 7.66×10-5 0.006 131 48585 





Regulation of axon 
extension involved in 
axon guidance 
BP 9.42 8.13×10-5 0.006 7 48841 
Negative regulation of 
biological process 
BP 9.26 9.50×10-5 0.007 456 48519 
Regulation of small 
gtpase mediated signal 
transduction 
BP 9.26 9.55×10-5 0.007 56 51056 
Regulation of purine 
nucleotide metabolic 
process 
BP 9.24 9.69×10-5 0.007 72 1900542 
Cell development BP 9.12 0.0001 0.007 79 48468 
Negative regulation of 
cell communication 
BP 9.04 0.0001 0.008 114 10648 
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Gated channel activity MF 9.03 0.0001 0.008 60 22836 
Ion gated channel 
activity 
MF 9.03 0.0001 0.008 60 22839 
DNA binding MF 9.00 0.0001 0.008 351 3677 
Response to stimulus BP 8.99 0.0001 0.008 827 50896 
Positive regulation of 
nitrogen compound 
metabolic process 
BP 8.94 0.0001 0.008 196 51173 
Regulation of nucleotide 
metabolic process 
BP 8.91 0.0001 0.008 72 6140 
Channel activity MF 8.88 0.0001 0.008 76 15267 
Passive transmembrane 
transporter activity 
MF 8.88 0.0001 0.008 76 22803 
Organ morphogenesis BP 8.80 0.0002 0.009 76 9887 
Extracellular matrix 
disassembly 
BP 8.78 0.0002 0.009 22 22617 
Negative regulation of BP 8.74 0.0002 0.009 113 23057 
 48 
signaling 
Negative regulation of 
cellular process 
BP 8.67 0.0002 0.01 421 48523 
Neuron projection CC 8.64 0.0002 0.01 80 43005 
Cell projection part CC 8.61 0.0002 0.01 111 44463 
Positive regulation of 
cellular metabolic 
process 
BP 8.61 0.0002 0.01 292 31325 
Positive regulation of 
RNA metabolic process 
BP 8.52 0.0002 0.01 173 51254 
Regulation of cellular 
component organization 
BP 8.51 0.0002 0.01 202 51128 
Intracellular part CC 8.51 0.0002 0.01 1607 44424 
Enzyme regulator 
activity 
MF 8.51 0.0002 0.01 161 30234 
Positive regulation of 
metabolic process 
BP 8.48 0.0002 0.01 306 9893 
 49 
Regulation of Ras 
protein signal 
transduction 




BP 8.45 0.0002 0.01 275 51239 
Cation channel activity MF 8.40 0.0002 0.01 54 5261 
Negative regulation of 
canonical Wnt receptor 
signaling pathway 
BP 8.39 0.0002 0.01 22 90090 
Collagen metabolic 
process 
BP 8.39 0.0002 0.01 22 32963 
Plasma membrane part CC 8.38 0.0002 0.01 284 44459 
Collagen CC 8.37 0.0002 0.01 24 5581 
Locomotion BP 8.34 0.0002 0.01 159 40011 
Regulation of 
multicellular organismal 
BP 8.27 0.0003 0.01 178 2000026 
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development 
Regulation of Wnt 
receptor signaling 
pathway 
BP 8.25 0.0003 0.01 40 30111 
Collagen catabolic 
process 
BP 8.25 0.0003 0.01 20 30574 
Multicellular organismal 
metabolic process 
BP 8.20 0.0003 0.01 24 44236 
Regulation of 
localization 
BP 8.14 0.0003 0.01 214 32879 
Connective tissue 
development 
BP 8.08 0.0003 0.01 26 61448 
Positive regulation of 
transcription, DNA-
dependent 
BP 8.07 0.0003 0.01 164 45893 
Positive regulation of 
gtpase activity 
BP 8.06 0.0003 0.01 34 43547 
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Positive regulation of 
macromolecule 
metabolic process 
BP 7.97 0.0003 0.02 284 10604 
Neuron fate commitment BP 7.96 0.0004 0.02 11 48663 
Ionotropic glutamate 
receptor complex 
CC 7.96 0.0004 0.02 11 8328 
Synaptic membrane CC 7.95 0.0004 0.02 45 97060 
Multicellular organismal 
catabolic process 
BP 7.93 0.0004 0.02 21 44243 
Ion transmembrane 
transporter activity 
MF 7.90 0.0004 0.02 127 15075 
Cellular component 
organization 
BP 7.86 0.0004 0.02 491 16043 
Establishment of 
localization 
BP 7.84 0.0004 0.02 427 51234 
Embryonic placenta 
development 
BP 7.84 0.0004 0.02 10 1892 
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Localization BP 7.84 0.0004 0.02 71 51179 
Tissue development BP 7.83 0.0004 0.02 96 9888 
Regulation of canonical 
Wnt receptor signaling 
pathway 
BP 7.68 0.0005 0.02 30 60828 
Energy reserve 
metabolic process 
BP 7.67 0.0005 0.02 32 6112 
Regulation of cellular 
component biogenesis 
BP 7.67 0.0005 0.02 68 44087 
Membrane-bounded 
vesicle 
CC 7.66 0.0005 0.02 104 31988 
Intracellular signal 
transduction 
BP 7.65 0.0005 0.02 206 35556 
Regulation of Rho 
protein signal 
transduction 
BP 7.59 0.0005 0.02 23 35023 
Axis specification BP 7.52 0.0005 0.02 18 9798 
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Ion channel complex CC 7.50 0.0006 0.02 41 34702 
Microtubule motor 
activity 
MF 7.48 0.0006 0.02 20 3777 
Signaling BP 7.46 0.0006 0.02 118 23052 
Single organism 
signaling 
BP 7.46 0.0006 0.02 118 44700 
Negative regulation of 
Wnt receptor signaling 
pathway 
BP 7.44 0.0006 0.02 27 30178 
Embryonic organ 
morphogenesis 
BP 7.44 0.0006 0.02 27 48562 
Cell-cell signaling BP 7.44 0.0006 0.02 115 7267 
Positive regulation of 
gene expression 




BP 7.32 0.0007 0.02 22 44259 
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Establishment or 
maintenance of cell 
polarity 
BP 7.32 0.0007 0.02 22 7163 
Regulation of 
developmental growth 
BP 7.32 0.0007 0.02 26 48638 
Lipid binding MF 7.30 0.0007 0.02 123 8289 
Regulation of cell 
proliferation 




MF 7.22 0.0007 0.03 134 22891 
Regulation of 
developmental process 
BP 7.21 0.0007 0.03 223 50793 
Taxis BP 7.16 0.0008 0.03 92 42330 
Chemotaxis BP 7.16 0.0008 0.03 92 6935 
Ligand-gated ion 
channel activity 




MF 7.15 0.0008 0.03 30 22834 
Cell fate determination BP 7.15 0.0008 0.03 13 1709 
Vesicle CC 7.13 0.0008 0.03 116 31982 
Negative regulation of 
cell development 
BP 7.02 0.0009 0.03 27 10721 
Wnt receptor signaling 
pathway 




BP 7.02 0.0009 0.03 491 71840 
Positive regulation of 
biological process 
BP 7.00 0.0009 0.03 513 48518 
Membrane CC 6.94 0.0010 0.03 801 16020 
Regulation of metabolic 
process 
BP 6.92 0.0010 0.03 672 19222 
Positive regulation of BP 6.90 0.0010 0.03 118 45944 
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transcription from RNA 
polymerase II promoter 
Negative regulation of 
axonogenesis 
BP 6.90 0.0010 0.03 13 50771 
Regulation of respiratory 
gaseous exchange 
BP 6.89 0.0010 0.03 8 43576 
Transport BP 6.87 0.0010 0.03 416 6810 
Transport vesicle 
membrane 
CC 6.86 0.0011 0.03 17 30658 
Energy derivation by 
oxidation of organic 
compounds 
BP 6.85 0.0011 0.03 37 15980 
Positive regulation of 
cell development 
BP 6.84 0.0011 0.03 33 10720 
Regulation of cell 
adhesion 
BP 6.82 0.0011 0.03 51 30155 
Actin filament-based BP 6.82 0.0011 0.03 54 30029 
 57 
process 
Cell surface receptor 
signaling pathway 
BP 6.81 0.0011 0.03 312 7166 
Cell-cell junction CC 6.79 0.0011 0.03 52 5911 
Activation of Ras gtpase 
activity 
BP 6.79 0.0011 0.03 10 32856 
Chromatin binding MF 6.73 0.0012 0.04 62 3682 





BP 6.70 0.0012 0.04 487 19219 
Negative regulation of 
neurogenesis 
BP 6.69 0.0012 0.04 22 50768 
Microtubule associated 
complex 
CC 6.64 0.0013 0.04 29 5875 





CC 6.57 0.0014 0.04 21 31901 
Cation channel complex CC 6.52 0.0015 0.04 29 34703 
Positive regulation of 
neurogenesis 
BP 6.49 0.0015 0.04 26 50769 
Coated vesicle 
membrane 




BP 6.42 0.0016 0.05 7 2066 
Regulation of steroid 
biosynthetic process 
BP 6.42 0.0016 0.05 13 50810 
ER to Golgi transport 
vesicle membrane 
CC 6.42 0.0016 0.05 11 12507 
Dynein complex CC 6.40 0.0017 0.05 12 30286 




Site of polarized growth CC 6.39 0.0017 0.05 22 30427 
Skeletal system 
morphogenesis 
BP 6.37 0.0017 0.05 23 48705 
Negative regulation of 
intracellular protein 
kinase cascade 




BP 6.33 0.0018 0.05 3 35726 
Regulation of 
somitogenesis 




BP 6.33 0.0018 0.05 3 34287 




BP 6.33 0.0018 0.05 3 9730 
Detection of hexose 
stimulus 




MF 6.33 0.0018 0.05 3 5010 
Laminin-10 complex CC 6.33 0.0018 0.05 3 43259 
Cell projection CC 6.26 0.0019 0.05 139 42995 
Multicellular organismal 
development 
BP 6.25 0.0019 0.05 81 7275 
Positive regulation of 
Ras gtpase activity 
BP 6.23 0.0020 0.05 23 32320 
Endoplasmic reticulum 
part 
CC 6.22 0.0020 0.05 142 44432 
Regulation of GTP 
catabolic process 
BP 6.21 0.0020 0.05 44 33124 
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Regulation of nitrogen 
compound metabolic 
process 
BP 6.20 0.0020 0.05 495 51171 
Neuron recognition BP 6.19 0.0020 0.05 10 8038 
Negative regulation of 
cell proliferation 
BP 6.17 0.0021 0.05 88 8285 
Regulation of cellular 
metabolic process 
BP 6.16 0.0021 0.05 612 31323 
Negative regulation of 
axon extension involved 
in axon guidance 
BP 6.14 0.0022 0.05 5 48843 
Negative regulation of 
JAK-STAT cascade 




CC 6.14 0.0022 0.05 5 17146 
Regulation of BP 6.10 0.0022 0.05 22 50770 
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axonogenesis 
Neuron differentiation BP 6.09 0.0023 0.06 38 30182 
Cytoskeleton 
organization 
BP 6.05 0.0024 0.06 93 7010 




BP 6.01 0.0025 0.06 48 9118 
Establishment of protein 
localization to 
membrane 
BP 5.98 0.0025 0.06 9 90150 
Integral to endoplasmic 
reticulum membrane 
CC 5.97 0.0025 0.06 21 30176 




BP 5.97 0.0025 0.06 6 60351 
 63 
morphogenesis 
Enzyme linked receptor 
protein signaling 
pathway 
BP 5.96 0.0026 0.06 112 7167 
Intramembranous 
ossification 
BP 5.93 0.0027 0.06 4 1957 
Direct ossification BP 5.93 0.0027 0.06 4 36072 
Regulation of transport BP 5.91 0.0027 0.06 157 51049 
Embryonic skeletal 
system morphogenesis 
BP 5.90 0.0027 0.06 18 48704 
Regulation of catabolic 
process 
BP 5.90 0.0027 0.06 88 9894 
Regulation of gtpase 
activity 
BP 5.90 0.0027 0.06 43 43087 
Transmembrane 
receptor protein tyrosine 
kinase signaling 





CC 5.85 0.0029 0.07 16 70062 
Antigen processing and 
presentation of 
exogenous peptide 
antigen via MHC class II 
BP 5.83 0.0029 0.07 21 19886 
Tight junction CC 5.83 0.0029 0.07 23 5923 




MF 5.83 0.0029 0.07 22 4867 
Cellular component 
movement 
BP 5.83 0.0029 0.07 138 6928 
Membrane-enclosed 
lumen 
CC 5.78 0.0031 0.07 101 31974 
Vesicle membrane CC 5.77 0.0031 0.07 61 12506 
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Regulatory region 
nucleic acid binding 
MF 5.77 0.0031 0.07 62 1067 
Regulatory region DNA 
binding 
MF 5.77 0.0031 0.07 62 975 
Regulation of primary 
metabolic process 
BP 5.76 0.0031 0.07 601 80090 
Regulation of purine 
nucleotide catabolic 
process 
BP 5.72 0.0033 0.07 47 33121 
Cartilage development BP 5.72 0.0033 0.07 19 51216 
Response to glucagon 
stimulus 




BP 5.70 0.0034 0.07 98 22603 
Cytoplasmic vesicle 
membrane 
CC 5.65 0.0035 0.07 59 30659 
 66 
Regulation of biological 
quality 
BP 5.65 0.0035 0.07 314 65008 
Regulation of nucleotide 
catabolic process 




MF 5.64 0.0036 0.08 65 46873 
Ionotropic glutamate 
receptor activity 
MF 5.62 0.0036 0.08 7 4970 




BP 5.60 0.0037 0.08 31 32872 
Single-organism 
transport 
BP 5.59 0.0037 0.08 323 44765 
Regulation of cellular 
localization 
BP 5.58 0.0038 0.08 111 60341 
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Antigen processing and 
presentation of peptide 
antigen via MHC class II 
BP 5.56 0.0038 0.08 21 2495 
Response to 
endogenous stimulus 
BP 5.56 0.0039 0.08 156 9719 
Actin cytoskeleton 
organization 
BP 5.55 0.0039 0.08 44 30036 
Anchoring collagen CC 5.55 0.0039 0.08 5 30934 
Axonal growth cone CC 5.55 0.0039 0.08 5 44295 
Mannose metabolic 
process 
BP 5.55 0.0039 0.08 5 6013 
Semaphorin-plexin 
signaling pathway 
BP 5.52 0.0040 0.08 6 71526 
Biological adhesion BP 5.52 0.0040 0.08 121 22610 
Cell adhesion BP 5.52 0.0040 0.08 121 7155 
Extracellular organelle CC 5.51 0.0040 0.08 16 43230 




activated protein kinase 
signaling cascade 
BP 5.50 0.0041 0.08 31 70302 
Positive regulation of 
insulin secretion 
BP 5.50 0.0041 0.08 12 32024 
Macromolecule 
localization 
BP 5.47 0.0042 0.08 57 33036 
Intrinsic to endoplasmic 
reticulum membrane 
CC 5.46 0.0043 0.08 23 31227 
Homeostatic process BP 5.45 0.0043 0.08 152 42592 
Transmembrane 
transporter activity 
MF 5.44 0.0043 0.08 141 22857 
Endocytosis BP 5.44 0.0044 0.08 46 6897 
Negative regulation of 
cell adhesion 
BP 5.43 0.0044 0.08 20 7162 






BP 5.41 0.0045 0.09 10 48706 
Protein binding MF 5.40 0.0045 0.09 965 5515 
Small gtpase mediated 
signal transduction 
BP 5.36 0.0047 0.09 71 7264 
Regulation of steroid 
metabolic process 
BP 5.35 0.0047 0.09 16 19218 
Secretion by cell BP 5.33 0.0048 0.09 63 32940 
Liver development BP 5.32 0.0049 0.09 17 1889 
Antigen processing and 
presentation of peptide 
or polysaccharide 
antigen via MHC class II 
BP 5.30 0.0050 0.09 21 2504 
Epithelial tube 
morphogenesis 
BP 5.29 0.0050 0.09 19 60562 
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Regulation of response 
to stimulus 
BP 5.28 0.0051 0.09 348 48583 
Gtpase activator activity MF 5.27 0.0051 0.09 47 5096 
Organelle CC 5.27 0.0051 0.09 1126 43226 
Extracellular-glutamate-
gated ion channel 
activity 
MF 5.27 0.0051 0.09 7 5234 
Osteoblast development BP 5.27 0.0051 0.09 7 2076 
Adherens junction CC 5.25 0.0053 0.10 37 5912 
Cardiac septum 
morphogenesis 
BP 5.22 0.0054 0.10 11 60411 
Cation transmembrane 
transporter activity 
MF 5.22 0.0054 0.10 94 8324 
Secretion BP 5.22 0.0054 0.10 75 46903 
Regulation of insulin 
secretion 
BP 5.21 0.0054 0.10 29 50796 
Regulation of peptide BP 5.21 0.0055 0.10 31 90276 
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hormone secretion 
Regulation of hormone 
secretion 
BP 5.19 0.0056 0.10 36 46883 
Dorsal spinal cord 
development 




BP 5.19 0.0056 0.10 4 32287 
Positive regulation of 
superoxide anion 
generation 
BP 5.19 0.0056 0.10 4 32930 
Lipid particle 
organization 
BP 5.19 0.0056 0.10 4 34389 
Morphogenesis of an 
epithelium 
BP 5.17 0.0057 0.10 50 2009 
Positive regulation of 
hormone secretion 
BP 5.17 0.0057 0.10 17 46887 
 72 
Establishment of protein 
localization to plasma 
membrane 
BP 5.17 0.0057 0.10 8 90002 
Rab guanyl-nucleotide 
exchange factor activity 
MF 5.17 0.0057 0.10 8 17112 
Negative regulation of 
osteoblast differentiation 
BP 5.17 0.0057 0.10 10 45668 
Response to chemical 
stimulus 
BP 5.16 0.0057 0.10 366 42221 
Ras gtpase activator 
activity 
MF 5.16 0.0057 0.10 25 5099 
Response to nitrogen 
compound 
BP 5.15 0.0058 0.10 96 1901698 
Axonogenesis BP 5.13 0.0059 0.10 24 7409 
Regulation of JNK 
cascade 
BP 5.13 0.0059 0.10 27 46328 
Substrate-specific MF 5.12 0.0059 0.10 146 22892 
 73 
transporter activity 
Positive regulation of 
cell differentiation 
BP 5.12 0.0060 0.10 81 45597 
Cytoplasmic membrane-
bounded vesicle 
CC 5.11 0.0060 0.10 89 16023 
RNA biosynthetic 
process 
BP 5.11 0.0061 0.10 323 32774 
Regulation of secretion BP 5.10 0.0061 0.10 74 51046 
Regulation of cell-
substrate adhesion 
BP 5.10 0.0061 0.10 23 10810 
Neuropeptide receptor 
activity 
MF 5.10 0.0061 0.10 12 8188 
Establishment of cell 
polarity 
BP 5.10 0.0061 0.10 12 30010 
Cellular component 
morphogenesis 
BP 5.09 0.0061 0.10 63 32989 
Cell fate commitment BP 5.09 0.0062 0.10 26 45165 
 74 
Positive regulation of 
secretion 
BP 5.09 0.0062 0.10 40 51047 
Golgi apparatus part CC 5.07 0.0063 0.10 103 44431 
Response to organic 
nitrogen 




BP 5.05 0.0064 0.10 5 10889 
Platelet-derived growth 
factor binding 
MF 5.05 0.0064 0.10 5 48407 
MHC class II receptor 
activity 
MF 5.05 0.0064 0.10 5 32395 
Positive regulation of 
neuron differentiation 




MF 5.04 0.0065 0.10 3 16286 
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activity 
Cardiac endothelial cell 
differentiation 
BP 5.04 0.0065 0.10 3 3348 
Endocardial cell 
differentiation 





MF 5.04 0.0065 0.10 3 50510 
Positive regulation of 
transcription of Notch 
receptor target 
BP 5.04 0.0065 0.10 3 7221 
Glossopharyngeal nerve 
morphogenesis 
BP 5.04 0.0065 0.10 3 21615 
Extracellular matrix-cell 
signaling 
BP 5.04 0.0065 0.10 3 35426 
Immunoglobulin BP 5.04 0.0065 0.10 3 2381 
 76 




Nerve growth factor 
processing 
BP 5.04 0.0065 0.10 3 32455 
Enzyme binding MF 5.04 0.0065 0.10 162 19899 
Cell recognition BP 5.03 0.0066 0.10 17 8037 
Regulation of peptide 
secretion 
BP 5.02 0.0066 0.10 31 2791 
Regulation of peptide 
transport 
BP 5.02 0.0066 0.10 31 90087 
Cytoplasmic vesicle part CC 4.99 0.0068 0.10 73 44433 
Skeletal system 
development 
BP 4.97 0.0069 0.11 30 1501 
Postsynaptic membrane CC 4.97 0.0070 0.11 35 45211 
Postsynaptic density CC 4.96 0.0070 0.11 22 14069 
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Bone morphogenesis BP 4.95 0.0071 0.11 7 60349 
Synaptic transmission, 
glutamatergic 
BP 4.95 0.0071 0.11 7 35249 
Cortical actin 
cytoskeleton 
CC 4.95 0.0071 0.11 7 30864 
Cellular response to 
glucagon stimulus 
BP 4.95 0.0071 0.11 10 71377 
Negative regulation of 
growth 
BP 4.94 0.0071 0.11 36 45926 
Regulation of 
transcription from RNA 
polymerase II promoter 
BP 4.92 0.0073 0.11 185 6357 
Embryonic digit 
morphogenesis 
BP 4.91 0.0074 0.11 12 42733 
Regulation of extent of 
cell growth 
BP 4.91 0.0074 0.11 12 61387 






CC 4.90 0.0075 0.11 16 8076 
Regulation of JAK-STAT 
cascade 




BP 4.88 0.0076 0.11 186 51174 
Gland development BP 4.84 0.0079 0.12 22 48732 
Anion binding MF 4.84 0.0079 0.12 380 43168 
Regulation of 
membrane potential 
BP 4.83 0.0080 0.12 34 42391 
Regulation of phosphate 
metabolic process 
BP 4.81 0.0081 0.12 184 19220 
Epithelial cell 
development 
BP 4.80 0.0082 0.12 24 2064 
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Embryonic heart tube 
morphogenesis 
BP 4.79 0.0083 0.12 14 3143 
Inner ear 
morphogenesis 
BP 4.79 0.0083 0.12 14 42472 
Regulation of vesicle-
mediated transport 
BP 4.79 0.0084 0.12 40 60627 
Clathrin-coated vesicle 
membrane 
CC 4.77 0.0085 0.12 19 30665 
Cell migration BP 4.77 0.0085 0.12 91 16477 
Central nervous system 
neuron differentiation 
BP 4.77 0.0085 0.12 15 21953 
Negative regulation of 
axon extension 
BP 4.75 0.0086 0.12 6 30517 
Protein kinase C activity MF 4.75 0.0086 0.12 6 4697 
Regulation of cellular 
catabolic process 
BP 4.75 0.0086 0.12 75 31329 









MF 4.73 0.0088 0.12 10 15179 
Embryo implantation BP 4.73 0.0088 0.12 10 7566 
Endocytic vesicle 
membrane 
CC 4.73 0.0088 0.12 22 30666 
Glycogen metabolic 
process 




BP 4.73 0.0088 0.12 12 6283 
Neuron projection 
morphogenesis 
BP 4.72 0.0089 0.12 32 48812 
Epidermis development BP 4.69 0.0092 0.13 28 8544 
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Regulation of actin 
filament-based process 
BP 4.68 0.0093 0.13 37 32970 
Cellular response to 
growth factor stimulus 
BP 4.68 0.0093 0.13 81 71363 
Response to nicotine BP 4.67 0.0094 0.13 9 35094 
Midbrain development BP 4.67 0.0094 0.13 9 30901 
Cell body CC 4.67 0.0094 0.13 44 44297 
Positive regulation of 
peptide hormone 
secretion 








BP 4.66 0.0095 0.13 366 44271 




BP 4.65 0.0095 0.13 7 60412 
Protein localization BP 4.65 0.0096 0.13 51 8104 
Regulation of actin 
cytoskeleton 
organization 
BP 4.64 0.0096 0.13 35 32956 
Regulation of cyclic 
nucleotide metabolic 
process 
BP 4.64 0.0096 0.13 25 30799 
Binding, bridging MF 4.64 0.0097 0.13 27 60090 
Neuronal cell body CC 4.64 0.0097 0.13 40 43025 
Canonical Wnt receptor 
signaling pathway 
BP 4.62 0.0099 0.13 17 60070 
Atrial septum 
morphogenesis 
BP 4.61 0.0099 0.13 5 60413 
Outer membrane-
bounded periplasmic 
CC 4.61 0.0099 0.13 5 30288 
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space 
Periplasmic space CC 4.61 0.0099 0.13 5 42597 
Detection of bacterium BP 4.61 0.0099 0.13 5 16045 
Endocytic recycling BP 4.61 0.0099 0.13 5 32456 
Microtubule CC 4.61 0.01 0.13 58 5874 
Positive regulation of 
transport 
BP 4.61 0.01 0.13 79 51050 
Hepatocyte 
differentiation 




BP 4.59 0.01 0.13 4 72015 
Hydrogen peroxide 
biosynthetic process 
BP 4.59 0.01 0.13 4 50665 
RNA-induced silencing 
complex 
CC 4.59 0.01 0.13 4 16442 
Rnai effector complex CC 4.59 0.01 0.13 4 31332 
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Regulation of dendritic 
cell antigen processing 
and presentation 
BP 4.59 0.01 0.13 4 2604 
Left/right axis 
specification 
BP 4.59 0.01 0.13 4 70986 
CARD domain binding MF 4.59 0.01 0.13 4 50700 
Neuron migration BP 4.59 0.01 0.13 21 1764 
Cellular localization BP 4.59 0.01 0.13 49 51641 
Regulation of cell 
morphogenesis involved 
in differentiation 
BP 4.59 0.01 0.13 34 10769 
Regulation of cellular 
component movement 
BP 4.58 0.01 0.13 73 51270 
Glucan metabolic 
process 
BP 4.55 0.01 0.13 12 44042 
Cellular glucan 
metabolic process 
BP 4.55 0.01 0.13 12 6073 
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Brain development BP 4.55 0.01 0.13 32 7420 
Transcription regulatory 
region DNA binding 
MF 4.55 0.01 0.13 58 44212 




BP 4.53 0.01 0.13 10 32651 
Biosynthetic process BP 4.52 0.01 0.13 507 9058 
Cytoplasmic vesicle CC 4.51 0.01 0.14 97 31410 
Positive regulation of 
peptide secretion 
BP 4.51 0.01 0.14 13 2793 
Positive regulation of 
cytokine biosynthetic 
process 
BP 4.49 0.01 0.14 14 42108 
Appendage 
morphogenesis 
BP 4.48 0.01 0.14 21 35107 




BP 4.45 0.01 0.14 9 35115 
Tight junction assembly BP 4.45 0.01 0.14 9 70830 
Positive regulation of 
cell adhesion 
BP 4.45 0.01 0.14 25 45785 
Cellular response to 
acid 
BP 4.44 0.01 0.14 11 71229 
Golgi membrane CC 4.43 0.01 0.14 80 139 
Asymmetric protein 
localization 
BP 4.42 0.01 0.14 6 8105 
Positive regulation of 
developmental process 
BP 4.42 0.01 0.14 106 51094 
Neuron development BP 4.41 0.01 0.15 22 48666 
Potassium channel 
activity 
MF 4.41 0.01 0.15 22 5267 
Regulation of camp 
metabolic process 
BP 4.41 0.01 0.15 22 30814 
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Cytoplasmic part CC 4.40 0.01 0.15 888 44444 
Intrinsic to plasma 
membrane 
CC 4.40 0.01 0.15 156 31226 
Coated vesicle CC 4.40 0.01 0.15 26 30135 
Clathrin-coated vesicle CC 4.40 0.01 0.15 24 30136 
Negative regulation of 
developmental growth 
BP 4.40 0.01 0.15 8 48640 
Insulin-like growth factor 
binding 
MF 4.40 0.01 0.15 8 5520 
Regulation of 
locomotion 
BP 4.39 0.01 0.15 73 40012 
Intracellular organelle CC 4.39 0.01 0.15 1114 43229 
Cellular response to 
vascular endothelial 
growth factor stimulus 
BP 4.38 0.01 0.15 7 35924 
Positive regulation of 
epithelial to 





BP 4.37 0.01 0.15 38 6352 
Calcium channel activity MF 4.37 0.01 0.15 21 5262 
Lung development BP 4.36 0.01 0.15 17 30324 
Regulation of 
gliogenesis 
BP 4.34 0.01 0.15 14 14013 
Regulation of axon 
extension 
BP 4.34 0.01 0.15 10 30516 
Positive regulation of 
cyclase activity 
BP 4.34 0.01 0.15 10 31281 
Aromatic compound 
biosynthetic process 




BP 4.32 0.01 0.15 370 1901362 
Organelle lumen CC 4.32 0.01 0.15 90 43233 
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Cellular_component CC 4.30 0.01 0.15 2166 5575 
Aminoglycan metabolic 
process 
BP 4.30 0.01 0.15 29 6022 
Digestive tract 
development 
BP 4.27 0.01 0.16 11 48565 




MF 4.26 0.01 0.16 74 22890 
Anterior/posterior axis 
specification 
BP 4.25 0.01 0.16 9 9948 
Cytoskeleton CC 4.23 0.01 0.16 106 5856 
Cellular membrane 
organization 
BP 4.23 0.01 0.16 64 16044 
Plasma membrane CC 4.23 0.01 0.16 488 5886 
Dopaminergic neuron 
differentiation 
BP 4.23 0.01 0.16 5 71542 
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Regulation of respiratory 
gaseous exchange by 
neurological system 
process 
BP 4.23 0.01 0.16 5 2087 
Positive regulation of 
Wnt receptor signaling 
pathway 
BP 4.22 0.01 0.16 16 30177 
Phosphoglucomutase 
activity 
MF 4.22 0.01 0.16 3 4614 
Microvillus assembly BP 4.22 0.01 0.16 3 30033 
Microvillus organization BP 4.22 0.01 0.16 3 32528 
Noradrenergic neuron 
differentiation 
BP 4.22 0.01 0.16 3 3357 
Positive regulation of 
Wnt receptor signaling 
pathway, planar cell 
polarity pathway 
BP 4.22 0.01 0.16 3 2000096 
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Response to oleic acid BP 4.22 0.01 0.16 3 34201 
Chemorepellent activity MF 4.22 0.01 0.16 3 45499 
Positive regulation of 
steroid hormone 
biosynthetic process 
BP 4.22 0.01 0.16 3 90031 
Membrane-bounded 
organelle 
CC 4.19 0.02 0.17 1000 43227 
Generation of precursor 
metabolites and energy 




BP 4.17 0.02 0.17 8 35567 
Microtubule-based 
movement 
BP 4.16 0.02 0.17 28 7018 
Heterocycle biosynthetic 
process 
BP 4.16 0.02 0.17 354 18130 






BP 4.13 0.02 0.17 6 5978 
Glucan biosynthetic 
process 
BP 4.13 0.02 0.17 6 9250 
Cell differentiation in 
hindbrain 
BP 4.13 0.02 0.17 6 21533 
MHC class II protein 
complex 
CC 4.13 0.02 0.17 6 42613 
Regulation of timing of 
cell differentiation 
BP 4.11 0.02 0.17 4 48505 
Glomerular epithelial cell 
development 
BP 4.11 0.02 0.17 4 72310 
Negative regulation of 
catenin import into 
nucleus 
BP 4.11 0.02 0.17 4 35414 
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Negative regulation of 
smooth muscle cell 
differentiation 
BP 4.11 0.02 0.17 4 51151 
Pinocytosis BP 4.11 0.02 0.17 4 6907 
Semaphorin receptor 
activity 
MF 4.11 0.02 0.17 4 17154 
RNA polymerase II core 
binding 
MF 4.11 0.02 0.17 4 993 
Regulation of glial cell 
differentiation 
BP 4.10 0.02 0.17 11 45685 
Regulation of stem cell 
proliferation 
BP 4.10 0.02 0.18 16 72091 
Extracellular matrix 
organization 
BP 4.09 0.02 0.18 43 30198 
Regulation of DNA 
binding 
BP 4.08 0.02 0.18 15 51101 





BP 4.07 0.02 0.18 12 32642 
Phagocytic vesicle 
membrane 
CC 4.07 0.02 0.18 12 30670 
Palate development BP 4.06 0.02 0.18 14 60021 
Regulation of cyclase 
activity 
BP 4.06 0.02 0.18 14 31279 
Cellular biosynthetic 
process 
BP 4.06 0.02 0.18 482 44249 
Positive regulation of 
gliogenesis 
BP 4.05 0.02 0.18 9 14015 
Tissue homeostasis BP 4.04 0.02 0.18 18 1894 
Regulation of cell 
projection organization 
BP 4.03 0.02 0.18 44 31344 
Extracellular structure 
organization 
BP 4.02 0.02 0.18 43 43062 
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Actin binding MF 4.01 0.02 0.19 58 3779 
Endosome membrane CC 4.00 0.02 0.19 51 10008 
Regulation of cell 
growth 
BP 3.98 0.02 0.19 48 1558 
Positive regulation of 
lyase activity 
BP 3.98 0.02 0.19 10 51349 
Response to fatty acid BP 3.98 0.02 0.19 10 70542 
Regulation of epithelial 
to mesenchymal 
transition 
BP 3.98 0.02 0.19 10 10717 
Tube morphogenesis BP 3.97 0.02 0.19 19 35239 
Macromolecule 
biosynthetic process 
BP 3.97 0.02 0.19 384 9059 
Embryo development 
ending in birth or egg 
hatching 
BP 3.97 0.02 0.19 37 9792 
Growth factor binding MF 3.96 0.02 0.19 21 19838 
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BP 3.96 0.02 0.19 30 2478 
Positive regulation of 
phagocytosis 
BP 3.96 0.02 0.19 8 50766 
Vesicle-mediated 
transport 
BP 3.94 0.02 0.19 112 16192 
Coated pit CC 3.94 0.02 0.19 11 5905 
Membrane organization BP 3.94 0.02 0.19 64 61024 
Glycosaminoglycan 
metabolic process 
BP 3.94 0.02 0.19 27 30203 
Divalent inorganic cation 
transmembrane 
transporter activity 
MF 3.94 0.02 0.19 27 72509 
Protein localization to 
membrane 
BP 3.93 0.02 0.19 14 72657 
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BP 3.92 0.02 0.20 22 904 
Anchoring junction CC 3.90 0.02 0.20 37 70161 
Regulation of 
transcription involved in 
cell fate commitment 
BP 3.89 0.02 0.20 5 60850 
Spinal cord association 
neuron differentiation 
BP 3.89 0.02 0.20 5 21527 
Intrinsic to internal side 
of plasma membrane 
CC 3.89 0.02 0.20 5 31235 
Dorsal/ventral axis 
specification 
BP 3.89 0.02 0.20 5 9950 
Regulation of respiratory 
system process 
BP 3.89 0.02 0.20 5 44065 




polymerase II, core 
complex 
CC 3.89 0.02 0.20 5 5665 
Actin monomer binding MF 3.89 0.02 0.20 5 3785 
Central nervous system 
neuron development 
BP 3.89 0.02 0.20 7 21954 
Mesenchymal cell 
development 
BP 3.89 0.02 0.20 7 14031 
Positive regulation of 
glial cell differentiation 
BP 3.89 0.02 0.20 7 45687 
Zinc ion binding MF 3.88 0.02 0.20 280 8270 
Positive regulation of 
adenylate cyclase 
activity 
BP 3.86 0.02 0.20 9 45762 
Endosomal part CC 3.86 0.02 0.20 53 44440 





region DNA binding 
BP 3.85 0.02 0.20 6 2000677 
Cytoskeletal protein 
binding 
MF 3.85 0.02 0.20 97 8092 
Regulation of cellular 
biosynthetic process 
BP 3.84 0.02 0.20 458 31326 
Regulation of molecular 
function 
BP 3.84 0.02 0.21 254 65009 
Anion transmembrane 
transporter activity 
MF 3.83 0.02 0.21 40 8509 
Polysaccharide 
metabolic process 
BP 3.83 0.02 0.21 15 5976 
Regulation of stem cell 
differentiation 
BP 3.83 0.02 0.21 15 2000736 





BP 3.81 0.02 0.21 10 32652 
Stem cell proliferation BP 3.81 0.02 0.21 10 72089 
Antigen processing and 
presentation of 
exogenous antigen 
BP 3.81 0.02 0.21 30 19884 
Myosin complex CC 3.80 0.02 0.21 14 16459 
Membrane part CC 3.80 0.02 0.21 808 44425 
Voltage-gated channel 
activity 
MF 3.80 0.02 0.21 31 22832 
Voltage-gated ion 
channel activity 
MF 3.80 0.02 0.21 31 5244 
Regulation of adenylate 
cyclase activity 
BP 3.79 0.02 0.21 13 45761 
Regulation of cartilage 
development 
BP 3.79 0.02 0.21 11 61035 
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Positive regulation of 
lipase activity 
BP 3.78 0.02 0.21 17 60193 
Organelle membrane CC 3.78 0.02 0.21 307 31090 
Positive regulation of 
JNK cascade 
BP 3.78 0.02 0.21 12 46330 
Regulation of cell 
motility 
BP 3.78 0.02 0.21 66 2000145 
Synapse CC 3.78 0.02 0.21 34 45202 
Positive regulation of 
cytoskeleton 
organization 
BP 3.77 0.02 0.21 21 51495 
Regulation of neuron 
projection development 
BP 3.77 0.02 0.21 36 10975 
Cell part morphogenesis BP 3.77 0.02 0.21 38 32990 
Cell differentiation in 
spinal cord 
BP 3.76 0.02 0.21 8 21515 
Face morphogenesis BP 3.76 0.02 0.21 8 60325 
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Stem cell development BP 3.76 0.02 0.21 8 48864 
Activation of adenylate 
cyclase activity 
BP 3.76 0.02 0.21 8 7190 
Embryo development BP 3.74 0.02 0.21 52 9790 
Heterocyclic compound 
binding 




BP 3.72 0.02 0.22 565 60255 
Stress-activated MAPK 
cascade 
BP 3.72 0.02 0.22 18 51403 
Regulation of RNA 
metabolic process 
BP 3.71 0.02 0.22 406 51252 
Hexose metabolic 
process 
BP 3.71 0.02 0.22 33 19318 
Cell projection 
organization 
BP 3.70 0.02 0.22 75 30030 
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Positive regulation of 
chemokine biosynthetic 
process 
BP 3.70 0.02 0.22 4 45080 
Hematopoietic stem cell 
proliferation 




BP 3.70 0.02 0.22 4 40034 
Apical protein 
localization 




BP 3.70 0.02 0.22 4 3222 
Positive regulation of 
protein sumoylation 
BP 3.70 0.02 0.22 4 33235 
Pre-mrna binding MF 3.70 0.02 0.22 4 36002 








BP 3.70 0.02 0.22 4 32928 
Activation of 
transmembrane receptor 
protein tyrosine kinase 
activity 
BP 3.70 0.02 0.22 4 7171 
DNA synthesis involved 
in DNA repair 
BP 3.70 0.02 0.22 4 731 
Positive regulation of 
SMAD protein import 
into nucleus 
BP 3.70 0.02 0.22 4 60391 
Basal transcription 
machinery binding 
MF 3.70 0.02 0.22 4 1098 
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Basal RNA polymerase 
II transcription 
machinery binding 
MF 3.70 0.02 0.22 4 1099 
Protein domain specific 
binding 
MF 3.69 0.03 0.22 79 19904 
Cellular response to 
endogenous stimulus 
BP 3.69 0.03 0.22 100 71495 
Heterotrimeric G-protein 
complex 
CC 3.69 0.03 0.22 9 5834 
Regulation of lyase 
activity 




MF 3.68 0.03 0.22 14 15171 
Voltage-gated cation 
channel activity 
MF 3.68 0.03 0.22 24 22843 
Axon part CC 3.68 0.03 0.22 24 33267 
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Positive regulation of 
protein catabolic 
process 
BP 3.68 0.03 0.22 17 45732 
Endoderm development BP 3.67 0.03 0.22 7 7492 
Chondroitin sulfate 
biosynthetic process 
BP 3.67 0.03 0.22 7 30206 
Dorsal/ventral pattern 
formation 
BP 3.66 0.03 0.22 13 9953 
Positive regulation of 
cell projection 
organization 
BP 3.65 0.03 0.22 25 31346 
Recycling endosome CC 3.64 0.03 0.22 12 55037 
Response to organic 
substance 








BP 3.63 0.03 0.22 460 9889 
Regulation of 
chemotaxis 
BP 3.63 0.03 0.22 20 50920 
Response to acid BP 3.62 0.03 0.22 18 1101 
Wnt receptor signaling 
pathway, calcium 
modulating pathway 
BP 3.62 0.03 0.22 3 7223 
Adenylate cyclase 
binding 
MF 3.62 0.03 0.22 3 8179 
Regulation of bile acid 
biosynthetic process 
BP 3.62 0.03 0.22 3 70857 
Neutrophil degranulation BP 3.62 0.03 0.22 3 43312 
Coumarin metabolic 
process 
BP 3.62 0.03 0.22 3 9804 
N-methyl-D-aspartate 
selective glutamate 
MF 3.62 0.03 0.22 3 4972 
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receptor activity 
FACIT collagen CC 3.62 0.03 0.22 3 5593 
WINAC complex CC 3.62 0.03 0.22 3 71778 
COPI-coated vesicle CC 3.62 0.03 0.22 3 30137 
Eukaryotic initiation 
factor 4E binding 
MF 3.62 0.03 0.22 3 8190 
Opioid receptor 
signaling pathway 
BP 3.62 0.03 0.22 3 38003 
Nerve growth factor 
binding 
MF 3.62 0.03 0.22 3 48406 
Somatic muscle 
development 
BP 3.62 0.03 0.22 3 7525 




BP 3.62 0.03 0.22 3 2000052 










BP 3.62 0.03 0.22 3 21797 
Glycine transmembrane 
transporter activity 
MF 3.62 0.03 0.22 3 15187 
Laminin-1 binding MF 3.62 0.03 0.22 3 43237 
Growth plate cartilage 
development 
BP 3.62 0.03 0.22 3 3417 




BP 3.62 0.03 0.22 3 61299 
Immunoglobulin BP 3.62 0.03 0.22 3 2377 
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production 
JUN kinase binding MF 3.62 0.03 0.22 3 8432 
Mitotic metaphase BP 3.62 0.03 0.22 3 89 
Sensory perception of 
sweet taste 
BP 3.62 0.03 0.22 3 50916 
Chloride channel 
regulator activity 
MF 3.62 0.03 0.22 3 17081 
Collagen biosynthetic 
process 
BP 3.62 0.03 0.22 3 32964 
Endothelial cell 
differentiation 
BP 3.60 0.03 0.22 6 45446 
Activation of Rho gtpase 
activity 
BP 3.60 0.03 0.22 6 32862 
Intracellular ligand-
gated ion channel 
activity 
MF 3.60 0.03 0.22 6 5217 
Microfilament motor MF 3.60 0.03 0.22 6 146 
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activity 
Positive regulation of 
endocytosis 
BP 3.59 0.03 0.22 15 45807 
Carbohydrate 
homeostasis 
BP 3.59 0.03 0.22 21 33500 
Glucose homeostasis BP 3.59 0.03 0.22 21 42593 
Response to arsenic-
containing substance 
BP 3.59 0.03 0.22 5 46685 
Alpha-mannosidase 
activity 




CC 3.59 0.03 0.22 5 35267 
Axonemal dynein 
complex 
CC 3.59 0.03 0.22 5 5858 
Tubulin-tyrosine ligase 
activity 
MF 3.59 0.03 0.22 5 4835 
 112 
Extracellular region part CC 3.58 0.03 0.22 160 44421 
Negative regulation of 
cell growth 
BP 3.57 0.03 0.22 25 30308 
Regulation of lipid 
biosynthetic process 
BP 3.57 0.03 0.22 19 46890 
Tissue remodeling BP 3.56 0.03 0.23 14 48771 
Regulation of cell 
morphogenesis 
BP 3.56 0.03 0.23 49 22604 
Intracellular membrane-
bounded organelle 




MF 3.53 0.03 0.23 23 15079 
Metalloendopeptidase 
activity 
MF 3.53 0.03 0.23 20 4222 
Negative regulation of 
cell projection 
BP 3.53 0.03 0.23 16 31345 
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organization 
Regulation of exocytosis BP 3.53 0.03 0.23 16 17157 




BP 3.52 0.03 0.23 18 31098 
Adenyl ribonucleotide 
binding 
MF 3.52 0.03 0.23 212 32559 
Cellular response to 
amino acid stimulus 
BP 3.52 0.03 0.23 9 71230 
In utero embryonic 
development 
BP 3.51 0.03 0.23 35 1701 
Phosphotransferase 
activity, alcohol group 
as acceptor 
MF 3.51 0.03 0.23 107 16773 
Intracellular organelle 
lumen 





BP 3.51 0.03 0.23 44 48011 
Embryonic organ 
development 
BP 3.50 0.03 0.23 21 48568 
Regulation of lipase 
activity 
BP 3.50 0.03 0.23 21 60191 
Skin development BP 3.50 0.03 0.23 10 43588 
Amide biosynthetic 
process 
BP 3.50 0.03 0.23 11 43604 
Protein kinase activity MF 3.48 0.03 0.24 91 4672 
Regulation of cell-cell 
adhesion 
BP 3.48 0.03 0.24 15 22407 
Epithelial cell 
differentiation 
BP 3.48 0.03 0.24 41 30855 
Embryonic limb 
morphogenesis 




BP 3.47 0.03 0.24 17 35113 
ATP binding MF 3.47 0.03 0.24 208 5524 




BP 3.46 0.03 0.24 7 33144 
Vesicle docking involved 
in exocytosis 
BP 3.46 0.03 0.24 7 6904 
Glutamate receptor 
activity 
MF 3.46 0.03 0.24 7 8066 
Ephrin receptor 
signaling pathway 
BP 3.46 0.03 0.24 7 48013 
Negative regulation of 
stress-activated MAPK 
cascade 
BP 3.46 0.03 0.24 7 32873 







BP 3.45 0.03 0.24 44 38179 
Transporter activity MF 3.43 0.03 0.24 170 5215 
Monosaccharide 
catabolic process 
BP 3.42 0.03 0.25 16 46365 
Notch signaling pathway BP 3.41 0.03 0.25 21 7219 
Positive regulation of 
stress-activated MAPK 
cascade 
BP 3.41 0.03 0.25 13 32874 
Positive regulation of 
cell-substrate adhesion 
BP 3.41 0.03 0.25 13 10811 
Organelle localization BP 3.41 0.03 0.25 13 51640 
Lysosomal membrane CC 3.41 0.03 0.25 26 5765 









MF 3.39 0.03 0.25 22 15085 
Chordate embryonic 
development 
BP 3.39 0.03 0.25 35 43009 
Endoplasmic reticulum 
lumen 
CC 3.39 0.03 0.25 29 5788 
Regulation of Ras 
gtpase activity 
BP 3.39 0.03 0.25 29 32318 
Antigen processing and 
presentation of peptide 
antigen 
BP 3.38 0.03 0.25 31 48002 
Response to amino acid 
stimulus 
BP 3.37 0.03 0.25 15 43200 
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Positive regulation of 
phospholipase activity 
BP 3.37 0.03 0.25 15 10518 
Transition metal ion 
binding 
MF 3.37 0.03 0.25 308 46914 
Negative regulation of 
response to external 
stimulus 
BP 3.37 0.03 0.25 23 32102 
Regulation of gene 
expression 
BP 3.37 0.03 0.25 455 10468 
Regulation of embryonic 
development 
BP 3.37 0.03 0.25 17 45995 
Macromolecule 
metabolic process 
BP 3.37 0.03 0.25 834 43170 
Cellular macromolecule 
biosynthetic process 
BP 3.37 0.03 0.25 355 34645 
Polysaccharide 
catabolic process 




BP 3.37 0.03 0.25 6 60612 
Cardiac cell 
development 
BP 3.37 0.03 0.25 6 55006 
Homeostasis of number 
of cells within a tissue 
BP 3.37 0.03 0.25 6 48873 
Negative regulation of 
protein kinase B 
signaling cascade 
BP 3.37 0.03 0.25 6 51898 
Regulation of 
interleukin-4 production 
BP 3.37 0.03 0.25 6 32673 
Regulation of RNA 
biosynthetic process 
BP 3.36 0.03 0.25 395 2001141 
Negative regulation of 
muscle cell 
differentiation 
BP 3.36 0.03 0.25 9 51148 




Negative regulation of 
epidermal growth factor 
receptor signaling 
pathway 
BP 3.36 0.03 0.25 9 42059 
Positive regulation of 
proteasomal protein 
catabolic process 
BP 3.36 0.03 0.25 9 1901800 
Integral to plasma 
membrane 
CC 3.35 0.04 0.25 145 5887 
MHC protein complex CC 3.35 0.04 0.25 10 42611 
RNA polymerase activity MF 3.35 0.04 0.25 10 34062 
DNA-directed RNA 
polymerase activity 
MF 3.35 0.04 0.25 10 3899 
Regulation of organ 
morphogenesis 
BP 3.34 0.04 0.25 25 2000027 
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Glandular epithelial cell 
development 
BP 3.34 0.04 0.25 4 2068 




MF 3.34 0.04 0.25 4 16868 
Positive regulation of 
translational initiation 
BP 3.34 0.04 0.25 4 45948 
Platelet alpha granule CC 3.34 0.04 0.25 4 31091 
Heart trabecula 
morphogenesis 
BP 3.34 0.04 0.25 4 61384 
Myelin maintenance BP 3.34 0.04 0.25 4 43217 
Regulation of Wnt 
receptor signaling 
pathway, planar cell 
polarity pathway 
BP 3.34 0.04 0.25 4 2000095 






MF 3.34 0.04 0.25 4 8239 
Positive regulation of 
steroid biosynthetic 
process 
BP 3.34 0.04 0.25 4 10893 
RNA polymerase core 
enzyme binding 
MF 3.34 0.04 0.25 4 43175 
Phosphorylation BP 3.34 0.04 0.25 96 16310 
Positive regulation of 
organ growth 
BP 3.32 0.04 0.25 5 46622 
Translation initiation 
factor binding 
MF 3.32 0.04 0.25 5 31369 
Nitric oxide mediated 
signal transduction 
BP 3.32 0.04 0.25 5 7263 
Organ formation BP 3.32 0.04 0.25 5 48645 
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Vitamin D receptor 
binding 




CC 3.32 0.04 0.25 5 43189 
Negative regulation of 
toll-like receptor 
signaling pathway 
BP 3.32 0.04 0.25 5 34122 
Nucleotide-sugar 
biosynthetic process 
BP 3.32 0.04 0.25 5 9226 
Regulation of cellular 
macromolecule 
biosynthetic process 
BP 3.31 0.04 0.25 426 2000112 
Calcium ion binding MF 3.29 0.04 0.25 99 5509 
Positive regulation of 
stress-activated protein 
kinase signaling 
BP 3.29 0.04 0.25 13 70304 
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cascade 
Positive regulation of 
phospholipase C activity 
BP 3.29 0.04 0.25 13 10863 
Monosaccharide 
metabolic process 
BP 3.27 0.04 0.25 36 5996 
Basement membrane CC 3.27 0.04 0.25 15 5604 
Hexose catabolic 
process 
BP 3.27 0.04 0.25 15 19320 
Positive regulation of 
neural precursor cell 
proliferation 




BP 3.27 0.04 0.25 7 34446 
Calcium-dependent cell-
cell adhesion 
BP 3.27 0.04 0.25 7 16339 
Enhancer sequence- MF 3.27 0.04 0.25 7 1158 
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specific DNA binding 
Regulated secretory 
pathway 
BP 3.27 0.04 0.25 7 45055 
Autophagic vacuole CC 3.27 0.04 0.25 7 5776 
Positive regulation of 
stem cell proliferation 
BP 3.26 0.04 0.25 12 2000648 
Activation of 
phospholipase C activity 
BP 3.26 0.04 0.25 12 7202 
Chondroitin sulfate 
metabolic process 
BP 3.26 0.04 0.25 12 30204 
Calmodulin binding MF 3.25 0.04 0.25 28 5516 
Positive regulation of 
interleukin-6 production 
BP 3.22 0.04 0.25 8 32755 
Regulation of actin 
filament 
depolymerization 
BP 3.22 0.04 0.25 8 30834 





BP 3.21 0.04 0.25 35 48858 
Actin cytoskeleton 
reorganization 
BP 3.20 0.04 0.25 9 31532 
Extracellular matrix 
binding 




BP 3.20 0.04 0.25 2 72488 
Prostaglandin-E 
synthase activity 
MF 3.20 0.04 0.25 2 50220 
Trehalose metabolic 
process 
BP 3.20 0.04 0.25 2 5991 
Seminiferous tubule 
development 
BP 3.20 0.04 0.25 2 72520 
Cardiac atrium BP 3.20 0.04 0.25 2 3209 
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morphogenesis 
Regulation of collateral 
sprouting in absence of 
injury 
BP 3.20 0.04 0.25 2 48696 
Spemann organizer 
formation 
BP 3.20 0.04 0.25 2 60061 
Regulation of exocyst 
localization 
BP 3.20 0.04 0.25 2 60178 
Dehydroascorbic acid 
transporter activity 




MF 3.20 0.04 0.25 2 55056 
Production of mirnas 
involved in gene 
silencing by mirna 
BP 3.20 0.04 0.25 2 35196 





BP 3.20 0.04 0.25 2 21979 
Collagen type IX CC 3.20 0.04 0.25 2 5594 




BP 3.20 0.04 0.25 2 10621 
Detection of 
endogenous stimulus 
BP 3.20 0.04 0.25 2 9726 
Autonomic nervous 
system development 
BP 3.20 0.04 0.25 2 48483 
Trophectodermal 
cellular morphogenesis 
BP 3.20 0.04 0.25 2 1831 
Sec61 translocon 
complex 
CC 3.20 0.04 0.25 2 5784 
Translocon complex CC 3.20 0.04 0.25 2 71256 
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Brain segmentation BP 3.20 0.04 0.25 2 35284 
Cell migration involved 
in endocardial cushion 
formation 
BP 3.20 0.04 0.25 2 3273 
Transcription initiation 
from RNA polymerase III 
promoter 




BP 3.20 0.04 0.25 2 48791 
Dendritic growth cone CC 3.20 0.04 0.25 2 44294 
Natriuretic peptide 
receptor activity 
MF 3.20 0.04 0.25 2 16941 
Metencephalon 
development 
BP 3.20 0.04 0.25 2 22037 
Diencephalon 
morphogenesis 
BP 3.20 0.04 0.25 2 48852 
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Cardiac vascular 
smooth muscle cell 
development 








BP 3.20 0.04 0.25 2 6391 
G-quadruplex DNA 
binding 
MF 3.20 0.04 0.25 2 51880 
Butyrate metabolic 
process 
BP 3.20 0.04 0.25 2 19605 
Chromosome movement 
towards spindle pole 
BP 3.20 0.04 0.25 2 51305 
Phenylpropanoid 
catabolic process 




BP 3.20 0.04 0.25 2 21796 
Regulation of defense 
response to bacterium 




BP 3.20 0.04 0.25 2 60099 
Positive regulation of 
phagocytosis, 
engulfment 
BP 3.20 0.04 0.25 2 60100 
Cellular pigmentation BP 3.20 0.04 0.25 2 33059 
Synaptic cleft CC 3.20 0.04 0.25 2 43083 





BP 3.20 0.04 0.25 2 1900145 
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Regulation of nodal 
signaling pathway 
involved in 
determination of lateral 
mesoderm left/right 
asymmetry 




BP 3.20 0.04 0.25 2 45196 
Establishment of 
neuroblast polarity 
BP 3.20 0.04 0.25 2 45200 
Sensory system 
development 
BP 3.20 0.04 0.25 2 48880 
Cardiac muscle cell 
myoblast differentiation 
BP 3.20 0.04 0.25 2 60379 
Collagen V binding MF 3.20 0.04 0.25 2 70052 




transcription from RNA 
polymerase II promoter 
involved in spinal cord 
motor neuron fate 
specification 
BP 3.20 0.04 0.25 2 21912 
Neural plate pattern 
specification 
BP 3.20 0.04 0.25 2 60896 
Neural plate 
regionalization 
BP 3.20 0.04 0.25 2 60897 
Synaptic vesicle 
clustering 
BP 3.20 0.04 0.25 2 97091 
Bombesin receptor 
activity 
MF 3.20 0.04 0.25 2 4946 
Locomotion involved in 
locomotory behavior 
BP 3.20 0.04 0.25 2 31987 
 134 
Regulation of 
transcription from RNA 




BP 3.20 0.04 0.25 2 1900094 
Nodal signaling pathway 
involved in 
determination of lateral 
mesoderm left/right 
asymmetry 
BP 3.20 0.04 0.25 2 1900164 




BP 3.20 0.04 0.25 2 38107 
Smooth muscle cell 
proliferation 




MF 3.20 0.04 0.25 2 97157 
Intestinal epithelial cell 
development 
BP 3.20 0.04 0.25 2 60576 
Negative regulation of 
cholesterol biosynthetic 
process 
BP 3.20 0.04 0.25 2 45541 
Negative regulation of 
cholesterol metabolic 
process 
BP 3.20 0.04 0.25 2 90206 
Actin polymerization-
dependent cell motility 
BP 3.20 0.04 0.25 2 70358 
Protein poly-ADP-
ribosylation 
BP 3.20 0.04 0.25 2 70212 
Viral assembly, 
maturation, egress, and 
release 
BP 3.20 0.04 0.25 2 19067 
 136 
Retinal blood vessel 
morphogenesis 
BP 3.20 0.04 0.25 2 61304 
Ornithine decarboxylase 
activator activity 
MF 3.20 0.04 0.25 2 42978 
Intestine smooth muscle 
contraction 
BP 3.20 0.04 0.25 2 14827 
Calcium-dependent 
protein kinase C activity 




MF 3.20 0.04 0.25 2 9931 
Laminin-11 complex CC 3.20 0.04 0.25 2 43260 
Positive regulation of 
hydrolase activity 
BP 3.19 0.04 0.25 69 51345 
Regulation of MAPK 
cascade 
BP 3.19 0.04 0.25 71 43408 




protein ligase binding 
MF 3.19 0.04 0.25 26 44389 
Transcription initiation 
from RNA polymerase II 
promoter 
BP 3.19 0.04 0.25 31 6367 
Regulation of purine 
nucleotide biosynthetic 
process 
BP 3.18 0.04 0.25 20 1900371 
Regulation of nucleotide 
biosynthetic process 
BP 3.18 0.04 0.25 20 30808 
Transcriptional 
repressor complex 
CC 3.18 0.04 0.25 13 17053 




BP 3.17 0.04 0.25 391 6355 
 138 
Positive regulation of 
purine nucleotide 
metabolic process 
BP 3.17 0.04 0.25 15 1900544 
Negative regulation of 
binding 
BP 3.17 0.04 0.25 15 51100 
Wnt receptor signaling 
pathway, planar cell 
polarity pathway 
BP 3.16 0.04 0.25 6 60071 
Regulation of 
establishment of planar 
polarity 
BP 3.16 0.04 0.25 6 90175 
Negative regulation of 
glial cell differentiation 
BP 3.16 0.04 0.25 6 45686 
Motor neuron axon 
guidance 
BP 3.16 0.04 0.25 6 8045 
Laminin binding MF 3.16 0.04 0.25 6 43236 
Regulation of cytokine BP 3.15 0.04 0.25 3 2739 
 139 




BP 3.15 0.04 0.25 3 19388 
Filtration diaphragm CC 3.15 0.04 0.25 3 36056 
Slit diaphragm CC 3.15 0.04 0.25 3 36057 
Relaxation of smooth 
muscle 
BP 3.15 0.04 0.25 3 44557 
Embryonic process 
involved in female 
pregnancy 
BP 3.15 0.04 0.25 3 60136 
Regulation of neuron 
migration 
BP 3.15 0.04 0.25 3 2001222 
Cellular extravasation BP 3.15 0.04 0.25 3 45123 
Interkinetic nuclear 
migration 
BP 3.15 0.04 0.25 3 22027 
CD4-positive or CD8- BP 3.15 0.04 0.25 3 43369 
 140 
positive, alpha-beta T 








CC 3.15 0.04 0.25 3 70776 
Trna transcription BP 3.15 0.04 0.25 3 9304 
Neuronal cell body 
membrane 
CC 3.15 0.04 0.25 3 32809 
Cell body membrane CC 3.15 0.04 0.25 3 44298 
MAP-kinase scaffold 
activity 
MF 3.15 0.04 0.25 3 5078 
Positive regulation of 
dendritic cell antigen 
processing and 
BP 3.15 0.04 0.25 3 2606 
 141 
presentation 
Nuclear envelope lumen CC 3.15 0.04 0.25 3 5641 
Laminin-1 complex CC 3.15 0.04 0.25 3 5606 
Cell cortex part CC 3.15 0.04 0.25 18 44448 
Enzyme activator 
activity 
MF 3.15 0.04 0.25 64 8047 
Protein secretion BP 3.14 0.04 0.26 12 9306 
Regulation of cell 
migration 
BP 3.13 0.04 0.26 61 30334 
Regulation of 
neurotransmitter levels 
BP 3.12 0.04 0.26 16 1505 
Visual perception BP 3.12 0.04 0.26 30 7601 
Dendrite CC 3.12 0.04 0.26 30 30425 
Detection of external 
stimulus 
BP 3.12 0.04 0.26 26 9581 
Monocarboxylic acid 
biosynthetic process 
BP 3.12 0.04 0.26 28 72330 
 142 
Central nervous system 
development 
BP 3.10 0.04 0.26 20 7417 
Activating transcription 
factor binding 
MF 3.10 0.04 0.26 11 33613 
Negative regulation of 
cellular response to 
growth factor stimulus 
BP 3.09 0.05 0.27 17 90288 
G-protein coupled 
peptide receptor activity 
MF 3.09 0.05 0.27 21 8528 
E-box binding MF 3.08 0.05 0.27 7 70888 
Myeloid cell activation 
involved in immune 
response 
BP 3.08 0.05 0.27 7 2275 
Vesicle docking BP 3.08 0.05 0.27 7 48278 
Excretion BP 3.07 0.05 0.27 10 7588 
Negative regulation of 
steroid biosynthetic 
BP 3.07 0.05 0.27 5 10894 
 143 
process 
SMAD protein signal 
transduction 
BP 3.07 0.05 0.27 5 60395 
External encapsulating 
structure part 
CC 3.07 0.05 0.27 5 44462 




MF 3.07 0.05 0.27 5 980 
Mannosidase activity MF 3.07 0.05 0.27 5 15923 
Positive regulation of 
neuroblast proliferation 
BP 3.07 0.05 0.27 5 2052 
Protein phosphatase 2A 
binding 












BP 3.07 0.05 0.27 5 2000311 
Protein targeting to 
plasma membrane 
BP 3.07 0.05 0.27 5 72661 
Muscle cell proliferation BP 3.07 0.05 0.27 5 33002 
Positive regulation of 
nucleotide metabolic 
process 
BP 3.07 0.05 0.27 15 45981 
Cellular polysaccharide 
metabolic process 
BP 3.07 0.05 0.27 13 44264 
Potassium ion transport BP 3.06 0.05 0.27 18 6813 
Lateral plasma 
membrane 
CC 3.06 0.05 0.27 8 16328 
 145 
Defense response to 
Gram-positive bacterium 
BP 3.06 0.05 0.27 8 50830 
Positive regulation of 
exocytosis 
BP 3.06 0.05 0.27 8 45921 
Receptor regulator 
activity 
MF 3.06 0.05 0.27 9 30545 
Cardiocyte 
differentiation 
BP 3.06 0.05 0.27 9 35051 
Forelimb 
morphogenesis 
BP 3.06 0.05 0.27 9 35136 
Positive regulation of 
axonogenesis 
BP 3.06 0.05 0.27 9 50772 
Phagocytosis BP 3.06 0.05 0.27 9 6909 
Cell-cell adhesion BP 3.06 0.05 0.27 54 16337 
Transcription regulatory 
region sequence-
specific DNA binding 





BP 3.05 0.05 0.27 434 10556 
Chemical homeostasis BP 3.04 0.05 0.27 107 48878 
Oxidation-reduction 
process 
BP 3.04 0.05 0.27 73 55114 
Leydig cell 
differentiation 
BP 3.04 0.05 0.27 4 33327 
Trabecula 
morphogenesis 
BP 3.04 0.05 0.27 4 61383 
Positive regulation of 
interferon-gamma 
biosynthetic process 
BP 3.04 0.05 0.27 4 45078 
Positive regulation of 
insulin-like growth factor 
receptor signaling 
pathway 
BP 3.04 0.05 0.27 4 43568 
 147 
Mitogen-activated 
protein kinase kinase 
binding 
MF 3.04 0.05 0.27 4 31434 
Regulation of non-
canonical Wnt receptor 
signaling pathway 
BP 3.04 0.05 0.27 4 2000050 
Chronic inflammatory 
response 
BP 3.04 0.05 0.27 4 2544 
Regulation of SMAD 
protein import into 
nucleus 
BP 3.04 0.05 0.27 4 60390 
Regulation of steroid 
hormone biosynthetic 
process 
BP 3.04 0.05 0.27 4 90030 
Histone H2A acetylation BP 3.04 0.05 0.27 4 43968 
Negative regulation of 
JUN kinase activity 
BP 3.04 0.05 0.27 4 43508 
 148 
Fibrillar collagen CC 3.04 0.05 0.27 4 5583 
Cellular response to 
chemical stimulus 
BP 3.03 0.05 0.27 214 70887 
Regulation of 
phospholipase activity 
BP 3.03 0.05 0.27 16 10517 
Positive regulation of 
locomotion 
BP 3.02 0.05 0.27 39 40017 
Fatty acid biosynthetic 
process 
BP 3.02 0.05 0.27 20 6633 
Telomere maintenance BP 3.02 0.05 0.27 12 723 
Steroid metabolic 
process 
BP 3.01 0.05 0.27 38 8202 
Golgi cisterna 
membrane 
CC 3.01 0.05 0.27 14 32580 
Peptide receptor activity MF 3.01 0.05 0.27 21 1653 
Epidermal growth factor 
receptor signaling 
BP 3.00 0.05 0.27 31 7173 
 149 
pathway 
Regulation of cytokine 
biosynthetic process 
BP 3.00 0.05 0.27 17 42035 
Positive regulation of 
MAPK cascade 
BP 3.00 0.05 0.27 30 43410 
Cellular chemical 
homeostasis 
BP 3.00 0.05 0.27 80 55082 
Nervous system 
development 
BP 2.99 0.05 0.27 44 7399 
Endopeptidase inhibitor 
activity 




CC 2.98 0.05 0.28 11 5793 
Extrinsic to internal side 
of plasma membrane 
CC 2.98 0.05 0.28 11 31234 






BP 2.96 0.05 0.28 13 32649 
Positive regulation of 
interleukin-1 beta 
production 
BP 2.96 0.05 0.28 6 32731 
Calcium activated cation 
channel activity 




BP 2.96 0.05 0.28 6 48713 
Neural tube 
development 
BP 2.96 0.05 0.28 6 21915 
Phosphatidylinositol 3-
kinase binding 
MF 2.96 0.05 0.28 6 43548 
Middle ear BP 2.96 0.05 0.28 6 42474 
 151 
morphogenesis 
Positive regulation of 
cellular component 
biogenesis 
BP 2.96 0.05 0.28 6 44089 
Cellular homeostasis BP 2.95 0.05 0.28 91 19725 
ERBB signaling 
pathway 
BP 2.94 0.05 0.28 31 38127 
Cellular macromolecule 
localization 
BP 2.94 0.05 0.29 36 70727 
Regulation of ERK1 and 
ERK2 cascade 
BP 2.93 0.05 0.29 21 70372 
Regulation of hydrolase 
activity 




BP 2.93 0.05 0.29 101 10627 








BP 2.92 0.05 0.29 9 55010 
Neuron-neuron synaptic 
transmission 
BP 2.92 0.05 0.29 9 7270 
Hindlimb 
morphogenesis 
BP 2.92 0.05 0.29 9 35137 
Regulation of cellular 
response to growth 
factor stimulus 
BP 2.92 0.05 0.29 26 90287 
Homophilic cell 
adhesion 
BP 2.92 0.05 0.29 24 7156 
Cellular response to 
organic substance 
BP 2.92 0.05 0.29 184 71310 
Protein tyrosine kinase MF 2.92 0.05 0.29 25 4713 
 153 
activity 
Locomotory behavior BP 2.92 0.05 0.29 25 7626 
Receptor activator 
activity 
MF 2.91 0.05 0.29 7 30546 
Negative regulation of 
gliogenesis 
BP 2.91 0.05 0.29 7 14014 
Golgi-associated vesicle CC 2.91 0.05 0.29 7 5798 
Positive regulation of 
proteolysis 
BP 2.91 0.05 0.29 14 45862 
Extracellular ligand-
gated ion channel 
activity 
MF 2.91 0.05 0.29 14 5230 
Telomere organization BP 2.91 0.05 0.29 12 32200 
Negative regulation of 
BMP signaling pathway 
BP 2.91 0.05 0.29 8 30514 
Frizzled binding MF 2.91 0.05 0.29 8 5109 
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